[1]

Odisha State Medical Corporation Limited OSMCL

(A Government of Odisha Undertaking)

CONVENT SQUARE, INFRONT OF RAM MANDIR,

BHUBANESWAR – 751007

Odisha

INVITATION OF EXPRESSION OF INTEREST

For

EMPANELMENT OF DRUG TESTING LABORATORIES

EOI No: OSMCL / QA / EOI /01/2015-16

Name of EOI Responder:

Address:

Last date and time for the receipt of EOI Response : Dt : 12th May 2015/4 PM

For details;

www.OSMCL.nic.in

Email: qaosmcl.od@nic.in

[2]

Sl. No. Description Page No.

1 SECTION – I Invitation of Expression of Interest (EOI) 4

2 SECTION – II EOI Schedule 5

3 2.1 Important details of the EOI 5

4 2.2 Important Dates 5

5 SECTION – III Specific Conditions of EOI 6

6 3.1 Time Limits Prescribed 6

7 3.2 Prequalification Criteria 6

8 SECTION – IV General Conditions of Contract 8

9 4.1 EOI Document 8

10 4.2 Ernest Money Deposit (EMD) 11

11 4.3 Empanelment policy 12

12 4.4 Contents of the EOI documents 14

13 4.5 Evaluation of EOI 16

14 4.6 Inspection of Drugs Testing Facilities 17

15 4.7 Acceptance / Rejection of offers 18

16 4.8 Award of Contract 18

17 4.9 Testing & Reporting Conditions 20

18 4.10 Payment Provisions 22

19 4.12 Applicable Law & Jurisdiction of Courts 22

20 4.13 Corrupt or Fraudulent Practices 23

21 4.14 Force Majeure 24

22 4.15 Procedure for Blacklisting 24

23 4.17 Termination of Contract 25

[3]

Sl. No. Description Page no.

24 Annexure - I Checklist 27

25 Annexure – II Details of Analytical Laboratory 29

26 Annexure – III List of Sophisticated Analytical Drugs Equipments / Apparatus available in Lab.

31

27 Annexure – IV Performa for performance statement 32

28 Annexure – V Annual Turnover Statement 33

29 Annexure – VI Declaration 34

30 Annexure – VII Format of Bank guarantee for Security Deposit

35

31 Annexure – VIII Agreement Format 37

32 Annexure- IX List of items required to be tested in Generic names.

42 – 77

33 Annexure- X PRICE BID

List of item with testing rates are to be offered by the Laboratories.

78 – 130

[4]

SECTION I

INVITION OF EXPRESSION OF INTEREST

1.1 The Odisha Medical Services Corporation Limited – hereinafter mentioned

in this document as OSMCL or the Corporation – is a fully owned Government of Odisha company. One of the key objectives of the OSMCL is to act as the central procurement agency for all essential Drugs, other consumables, equipments for Health & Family Welfare Department.

1.2 The Corporation invites applications in the form of Expression of Interest –

EOI in short- for Empanelment of Drug Testing Laboratories for the analysis of Drugs, Medical Devices, Supplies, Surgical Sutures etc. more specifically mentioned in Annexure-IX for a period of 2 years from the date of acceptance. The Managing Director of the Corporation is the Expression of Interest Inviting Authority for this purpose.

1.3 Laboratories who offer lowest rates to undertake complete testing and

analysis of the Drugs, other medical supplies and consumables as mentioned in Annexure-IX and other laboratories willing to match L-1 rates as well as accept the terms and conditions as prescribed under the EOI documents are eligible to be selectedas th ‘Empanelled Drug Testing laboratory of OSMCL’.

1.4 Performance of the tests/ analysis strictly in accordance with the official/

recognized parameters of standards and delivery of test/ analysis reports in time and consistency of the analysis results are the most important factors to be adhered to by the Empanelled Laboratories.

1.5 The period of contract shall be two years from the date specified in the

agreement to be executed for the purpose of the contract. The EOI offerer shall give firmness of the rate prescribed and agreed upon for a period of two years from the date of agreement.

[5]

SECTION II

EOI SCHEDULE

2.1 Important details of the EOI:

1. EOI No. OSMCL/QA/01/2015-16

2. Cost of EOI Document Rs1000/-

3. Earnest Money Deposit Rs25000/- (refundable)

4. Form of Earnest Money Deposit

Demand Draft

5. Validity of EMD 180 days from the date of opening of technical document

6. Performance Security Deposit

Rs25,000/-

7. Validity of Performance Security deposit

30 months from the date of execution of agreement

2.2 Important Dates :

Sl. No. Particulars Date and time Venue

1. Date and time of commencement of sale of EOI document

10th April 2015 11 A.M

Hea

d O

ffic

e, O

SMC

L 2. Date and time of pre-offer meeting 17th April 2015 11:30 A.M

3. Last date and time of receipt of offers

12th May 2015 4 P.M.

4. Date and time of opening of the offers

13th May 2015 11.00 A.M

5. Date and time of opening of price-bid in cover-B

To be informed to the qualified bidders

[6]

SECTION – III SPECIFIC CONDITIONS OF EOI

3.1 Time Limits :

The Empanelled Drugs testing Laboratory shall furnish test reports at the Corporation with in the time limit specified below :

Category Permitted from the date of receipt of sample*

Penalty for delayed reporting

All non-sterile Preparations 15 days* @ 0.5% per day of the

delayed reporting up to a max of 10%

All sterile Preparations 30 days

*In case of emergency OSMCL may seek the test to be done within 7 days with additional charges as per price schedule agreed upon.

Note: The time period shall be calculated from the date noted in the proof of delivery on the empanelled lab.

3.2 Prequalification Criteria :

3.2.1 The Laboratory presenting the EOI (Offer) shall have valid Approval under the Drugs and Cosmetics Rules, 1945, valid good Laboratory Practices (GLP) certificate issued by the competent authority under the Drugs and Cosmetics Rules and with valid NABL accreditation. No EOI shall be presented in respect of any drug or any other item in respect of which such approval / certificate / accreditation is not possessed by the offerer/lab.

3.2.2 The offerer should have standing in the field of testing and analysis of drugs / consumables & other supplies in respect of which the EOI has been made for the last three years. Annexure – IV.

3.2.3 Theofferer shall have an average annual turnover of not less than Rs 25 lakhs for the last three consecutive years i.e. 2011-2012, 2012-2013, 2013-2014.

[7]

3.2.4 The offerer shall be a stand-alone laboratory i.e. independent and not an in- house facility part of a manufacturing unit.

3.2.5 Theofferer should have undertaken analysis of drugs and supplies of similar nature for at least three Government departments / institutions / reputed manufacturers of drugs & supplies during the last three years.

(please see Annexure-II serial no.11).

3.2.6 The offerer should be one located anywhere in India and should not have

been blacklisted at anytime by Govt. of Odisha/OSMCL or blacklisted /

debarred by any other State / Central Government’s organization or one

whose approval had been suspended or revoked partially or in full by any

statutory authority.

[8]

SECTION – IV GENERAL CONDITIONS OF CONTRACT

4.1 EOI Document :

4.1.1 The terms and conditions governing the Empanelment of laboratories are

contained in this “EOI Document”. The document can be downloaded

from website www.osmcl.nic.in / https://tendersodisha.gov.in.

4.1.2 Failure to furnish any information / document as required in this EOI

document and submission of an offer not substantially responsive to it in

every respect shall be at the offerer’s risk and would result in the

rejection of the offer, without any notice.

4.1.3 It is mandatory to provide a check list as per Annexure- I as the facing

sheet for the EOI offer submitted so as to enable the Corporation to

prima facie verify the compliance of submission of requisite documents

at the time of opening of EOI. Failure to furnish the check list would

make the offer deemed as non-responsive and open for summary

rejection.

4.1.4 Language of EOI and other communications and signatories thereof: -

The EOI submitted, all documents accompanying it presented thereof

and all communications between the offerer and the EOI Inviting

Authority shall be in English language. Supporting documents in originals

or copies as the case may be, issued by a statutory authority or court and

furnished by the offerer for the purposes of this EOI or for any purpose

after empanelment, may in other Indian language provided, they are

accompanied by authenticated accurate translation of the relevant

passages in the English language in which case, for purposes of

interpretation of the offers, the English translation shall govern. Any

communication from the Corporation made by an officer of the

Corporation on behalf of the Managing Director shall be deemed as a

communication by the EOI Inviting Authority and any communication /

[9]

correspondences made or any paper signed by an Authorised Signatory

or (Specific) Power of Attorney (POA) Holder for the purpose of this EOI

shall be deemed as communication / correspondence made by the

offerer provided such POA has been presented along with the EOI in such

manner as specified.

4.1.5 The EOI and accompanying documents once submitted shall not be

altered in any manner and should not have any scope of ambiguity,

cutting, pasting, overwriting, masking, alteration etc. Modification of the

offer, of the nature and to the extent provided in this document prior to

the time and date set for submission will, however, be entertained. Any

overwriting / cutting / correction otherwise of inadvertent error in the

EOI made before its presentation it must be one authenticated with

signature of the offerer in full and such modifications as above that are

not duly authenticated would necessitate summary rejection of the EOI.

No such correction or modification as above in the accompanying

document will be considered and documents with corrections would

make the EOI defective / non-responsive.

4.1.6 The documentary evidences submitted along with the EOI shall be

produced duly self-attested by the offerer on every page and serially

numbered.

4.1.7 A copy of the complete EOI document duly signed on every page by the

offerer or the authorized representative shall be enclosed as part of the

EOI as proof of having read and accepted the terms and conditions of the

EOI document.

4.1.8 The EOI shall be a computer typed one and signed by the offerer or

person(s) duly authorized to bind the offerer to the Contract with

Corporation. The person signing the document shall have due Power of

Attorney madeby the Board of Directors / Partners / Proprietor / Society

/ Trust etc. in case where person other than the Managing

Director/Managing Partner/President or Chairman of the Society / Trust

etc. or sole Proprietor sings the document. The photo of the person

[10]

authorized to sign the document shall be affixed to the power of

Attorney with due authentication. Where the Managing Director /

Managing Partner or other such person as mentioned above or the sole

proprietor signs the EOI and accompanying documents a notarized

document attesting the signature of the person shall be furnished. The

Power of Attorney shall be in non-judicial stamp paper duly notarized.

4.1.9 An offer submitted in vague / ambiguous terms and the like, shall be

termed as non-responsive and shall be summarily rejected.

4.1.10 At any time prior to the dead line for submission of the EOI, the EOI

Inviting Authority may, for any reason, modify the EOI document by

amendment. The amendment will be published in the website in the

website of the Corporation and shall be binding to all prospective

offerers.

4.1.11 Pre-offer meeting will be held by the Corporation to explain briefly about

the requirements as well as the terms and conditions of the EOI

document and to get the views of the prospective offerer’s, as part of

ensuring transparency in the EOI process. Failure to attend the pre-offer

meeting will not be a disqualification, but will be a loss of opportunity for

the prospective offerer to understand the EOI terms & conditions. Date

of pre-offer meeting is mentioned in Section – II. Filled up EOI will be

accepted only after the date of pre-offer meeting.

4.1.12 The EOI shall be sent in sealed envelope by registered / Speed post or by

courier to the following address:

The Managing Director Odisha State Medical Corporation Ltd., Convent Square, In front of Ram Mandir Bhubaneswar – 751007, Odisha. Phone No. – (0674) 2380660 / 2380950,

E-mail:qaosmcl.od@nic.in

[11]

4.1.13 The envelope containing the EOI document is to be supper scribed with

the title “EXPRESSION OF INTEREST FOR EMPANELMENT OF DRUG

TESTING LABORATORIES”.

4.1.14 EOI sent by telex or fax or email is void. The EOI may be presented in

person also in sealed envelope, addressed and super scribed as above

before the time and date specified.

4.1.15 If the EOI is sent by registered/ speed post or by Courier, it should reach

the above office on or before the time and date stipulated in Section II.

The Corporation shall not be held liable for the delay in transit.

4.1.16 The offerer may modify or withdraw its offer, after the EOI submission,

provided that written notice of the modification or withdrawal is

received by the Corporation before the date of opening of the EOI. The

offerer’s modification or withdrawal notice shall be signed by the offerer

or his / her authorized representative, who has signed the original EOI

document by fax or email but should necessarily be followed by a signed

confirmation copy to be received at the head office of the Corporation

before the date of opening of the technical document.

4.2 Earnest Money Deposit (EMD) :

4.2.1 The EOI shall be accompanied by the EMD as prescribed. Non-submission

of sufficient EMD as mentioned in Section - II along with the Technical

document shall result in summary rejection of the EOI.

4.2.2 The EMD shall be in the form of demand draft drawn in favour of Odisha

State Medical Corporation Ltd. payable at Bhubaneswar’.

4.2.3 Cheque, Cash payment, Money Order, Fixed deposit, Bank Guarantee etc

will not be accepted as EMD and in such cases the EOI offer will be

rejected.

4.2.4 Laboratories fully owned by the Government / PSUs are exempted from

remittance of EMD subject to submission of valid documents.

[12]

4.2.5 EMD of unsuccessful offerers will be discharged / returned as soon as

possible within thirty days after publishing of the final list of successful

EOIs by the Corporation.

4.2.6 The successful offerer’s EMD will be discharged upon the offerer signing

the contract and furnishing the performance security. The EMD of

successful offerer may be adjusted towards the performance security

payable.

4.2.7 No interest will be paid for the EMD.

4.2.8 The EMD will be forfeited, if an offerer;

4.2.8.1 Misrepresents facts or submits false / fake documents during the EOI

process.

4.2.8.2 If the offerer willfully violates any terms and conditions of the EOI

documents.

4.2.8.3 If the offerer withdraws its bid after the opening of EOI document.

4.2.8.4 A successful offerer fails to sign the contract after issuance of Letter Of

Intent.

4.3 Empanelment Policy :

4.3.1 The list of drugs/supplies for which rates to be finalized for complete

Laboratory testings are attached as Annexure– IX.

4.3.2 The Testing Laboratories can offer the rates at which complete testing of

items are performed and the rates for testing shall be filled by the offerer

in Annexure – X in the format specified and shall be kept in a separate

sealed cover indicating name of EOI responder and super scribing ‘PRICE-

BID COVER-B’.The offered rates shall be inclusive of all cost and other

charges such as statutory taxes and levies. The EOI offering minimum

rate for testing will be selected for testing that item. The EOI document

and certificate must be submitted in separate sealed cover as COVER-A

[13]

and price-bid shall kept in single sealed cover in which it shall be super

scribed “EXPRESSION OF INTEREST FOR EMPANELMENT OF DRUG

TESTING LABORATORIES”.

4.3.3 The EOI Inviting Authority will publish the final testing rate(s) of items

based on L1in the website of the Corporation permitting the other

qualified laboratories to match with the final testing rate(s). The

Corporation will empanel such laboratories who can match the L1 rates

and after due confirmation their name (s) will be included in the panel.

[14]

4.4 Contents of the EOI Documents :

4.4.1 The EOI must be accompanied by the following documents in the sealed

cover submitted. The documents shall be in the format prescribed.

Sl. No.

Documents to be submitted Format

prescribed

1.

Checklist (Annexure-I) for the EOI and the list of documents enclosed, with their page nos. marked. The EOI and the documents should be serially numbered and arranged as per Annexure-I. The page number(s) of each document shall be show in the checklist.

PDF format in DVD & Hard Copy

2.

The Earnest Money Deposit, IF NOT EXEMPTED, shall be Rs.25,000/-. The Earnest Money Deposit shall be paid in the form of Demand Draft favoring, Odisha State Medical Corporation Ltd.Payable at Bhubaneswar. IF EXEMPTED as per cause 4.2.4 valid documentary evidence to prove the claim shall be furnished.

Hard Copy

3.

Copy of self-attested Documentary evidence for the constitution of the company / concern such as Memorandum and Article of Association, list of names and address of the Directors, along with self-attested copies of Form 32 wherever there is a change of Directors, current Partnership deed (Self attested copy) etc, Name and address of the Chairman/ President/ Managing Trustee, Secretary etc in the case of societies, trusts etc details of the Name, e-mail address of the firm and of such Managing Director / Partners / Proprietor / others responsible for the conduct of business and operation of the laboratory.

PDF format in DVD& Hard copy

4.

Annual turnover statement (Original) certified by the auditors for last three years i.e. 2011-12, 2012-13, 2013-14 as Annexure – V.

PDF format in DVD & Hard Copy

5.

Self-attested Photocopy of approval for testing of Drugs and the list of drugs approval for testing in the laboratory issued by the Drugs Control Authority and valid renewal with list of approved products for testing.

PDF format in DVD & Hard Copy

[15]

6. Self-attested Photocopy of valid GLP Certificate issued by the Drugs Control Authority and valid renewal / validity certificate.

PDF format in DVD & Hard Copy

7. Self-attested Photocopy of NABL accreditation certificate and its valid renewal.

PDF format in DVD & Hard Copy

8. Attested copy of certificate of registration for service tax. PDF format in DVD & Hard Copy

9.

Self-attested copies of audited Balance Sheet and Profit and Loss account for the last three years i.e. 2011-12, 2012-13, 2013-14.

PDF format in DVD & Hard Copy

10. The list of qualified personnel employed in the laboratory (Employees name, Qualification and experience)

PDF format in DVD & Hard Copy

11. The list of sophisticated analytical equipments & apparatus available in the laboratory as in Annexure – III

PDF format in DVD & Hard Copy

12. Duly filled performance statement Annexure - IV duly signed PDF format in DVD & Hard Copy

13 Declaration in the Proforma given in Annexure – VI PDF format in DVD & Hard Copy

14. Details of Analytical Laboratory in Annexure – II PDF format in DVD & Hard Copy

15.

COVER-‘B’, Price Bid of items as per Annexure – IX. The rate of testing fees quoted for items as per EOI conditions.

DVD in. Xl format & Hard Copy

16. EOI document signed by the offerer in all pages with office seal Hard Copy

17. Self-attested copy of PAN. PDF format in DVD & Hard Copy

[16]

4.5 Evaluation of EOI :

4.5.1 The opening of the EOI offer will be done by the Corporation in the

presence of the offerer or their representatives who choose to attend at

the respective time and place mentioned in Section II.

4.5.2 In the event of the specified date for EOI submission / opening being

declared holiday, the EOI submission opening shall be at the appointed

time and venue on the next working day.

4.5.3 The offerer shall be responsible for properly superscribing and sealing

the envelopes and The Corporation shall not be liable for inadvertent

opening of the envelopes before the time appointed for opening of the

offers.

4.5.4 The documents submitted as part of the offer shall be scrutinized by

committee constituted by the EOI Inviting Authority.

4.5.5 An EOI, at any stage of the evaluation process or thereafter, in the event

of being found concealment or misrepresentation of facts, in respect of

the claims of offer,shall be rejected and is liable to be black listed for a

period as decided by the EOI Inviting Authority.

4.5.6 The Corporation may waive any minor infirmity in an offer, which does

not constitute a material deviation, provided that the same shall not

prejudicially affect the interest of the other offerers.

4.5.7 No EOI may be withdrawn in the interval after the opening and

finalization of the EOIs. Withdrawal of an EOI during this interval will

result in the forfeiture of its EMD and black listing of the offerer for a

period up to 3 years immediately succeeding the offer year and the

offerer shall be ineligible to participate in any of the offers / tenders of

the Corporation for a period of 3 years.

[17]

4.6 Inspection of Testing Facilities of the Laboratory :

4.6.1 Inspection of the testing facility will be at the discretion of the EOI

Inviting Authority. Such inspection may be at any stage before or after

acceptance of the offer Award of Contract / empanelment.

4.6.2 All the testing facility in the lab will be subjected to inspection / auditing.

The offerer will have to provide necessary arrangements to conduct the

inspection of all the sections and failure to co-operate with the

inspection in showing the different facilities, will lead to disqualification.

Entry to all the areas of lab for testing shall be facilitated.

4.6.3 The recommendations of the Inspection team will not be communicated

to the offerer at their site and shall be reported later only. A summary of

finding without stating the recommendation / conclusions may, however,

be furnished to the laboratory soon after the inspection.

4.6.4 The availability of technical experts, analytical facility as claimed in the

EOI offer along with the compliance of standard operating procedures

adapted for each procedure including validation and calibration, shall be

evaluated by the team for considering the eligibility of the lab. Claims of

holding the valid NABL certificate / valid approval / GLP certificate will

not be of any avail, if the procedures or if the available facility are not in

proper condition or if contraventions of GLP norms are observed at the

time of inspection. In the event of failure to facilitate inspection,

obstruction to carry out the inspection, non-cooperation during the

inspection, failure to furnish any record needed for verification etc., and

the EOI offer will be rejected or agreement will be terminated, as the

case may be.

4.6.5 The minimum number of samples that could be tested at a time will be

one of the criteria for determining the acceptance/rejection of the lab.

The Inspection team shall also verify the capacity of the offerer in

fulfilling the requirement of the Corporation.

[18]

4.6.6 Copy of one full set of the EOI offer should be made available at the time

of inspection.

4.6.7 Originals of all the documents submitted in the EOI offer should be

produced for verification by the inspection team. Failure to produce of

the original document will result in the rejection of the offer.

4.7 Acceptance / Rejection of offers :

4.7.1 Acceptance / rejection of the EOI offer will be based on the decisions

taken on the evaluation of the submitted documents and inspection

report from the expert committee.

4.7.2 At any point of time before or after the award of contract, the EOI

inviting authority reserves the right to cancel or modify the contract in

respect all or any of the items of drugs or other consumables in respect

of an EOI for breach of the terms and condition of the EOI or of the

agreement thereof.

4.7.3 The EOI Inviting Authority or his authorised representative (s) has the

right to inspect the labs of offerers, before releasing any sample or at any

point of time during the continuance of offer and also has the right to

reject the offer or terminate / cancel the contract awarded and or to re-

test, based on adverse reports brought during such inspection of samples

may also be done by the EOI inviting Authority at any stage before or

during the operations of the contract, to evaluate the performance of the

laboratory and the EOI Inviting Authority may initiate deterrent or

punitive measures if the evaluation processes or the inspections so

indicate or necessitate.

4.8 Award of Contract :

4.8.1 The Corporation will notify the successful offerer (s) in writing, by

registered / speed post or by email that its / their offer(s) testing of drugs

and other items which have been selected by the EOI inviting Authority,

[19]

has been accepted. This notification is made by issuing a Letter of Intent

by the EOI Inviting Authority.

4.8.2 The successful offerer, upon receipt of the Latter of Intent shall execute

an agreement in the format prescribed, in a non-judicial Odisha stamp

paper of value of Rs. 100/- or of such revised as may be notified by the

Government (stamp duty to be paid by the offerer) within 15 days from

the date of the intimation from Corporation that his offer has been

accepted. The Specimen format of agreement is available in Annexure-

VIII

4.8.3 There will be a performance security deposit amounting toRs. 25,000/-

(Rupees twenty five thousand) which shall be submitted by the

successful offerer along with the agreement within 15 days from the date

of issuance of Letter Of intent, in the form of Demand Draft drawn in

favors of the Odisha State Medical Corporation Ltd. payable at

Bhubaneswar / Bank Guarantee in the formats as given in Annexure-VII

for a period of 30 months from the date of execution of the agreement.

4.8.4 If the successful offerer fails to execute the agreement and / or to

deposit the required performance security deposit within the time

specified or withdraws his offer after opening of the bid, his award of

contract will be cancelled and the Earnest money Deposit of the firm

shall stand forfeited and the laboratory shall also be blacklisted for a

period up to three years immediately succeeding the EOI year and the

offerer will be ineligible to participate in any of the offers/EOI processes

of the Corporation for a period of three years.

4.8.5 Theofferer shall not, at any time, assign, sub-let or make over the

contract or the benefit in full or part thereof to any person or persons,

what so ever.

4.8.6 Any notice or other communication sent by e-mail or by any other

electronic mode shall also be deemed to be due service of the notice/

communication.

[20]

4.8.7 In the event of any failure/ default/ deviations from the terms and

conditions of the EOI or the agreement thereof, of the successful

tendered with or without any quantifiable loss to the OSMCL, the

amount of the performance security is liable to be forfeited.

4.8.8 The OSMCL will release the Performance Security without any interest to

the empanelled laboratory (ies) on completion of all contractual

obligations.

4.8.9 If the empanelled laboratorywithdraws from the contract during the

period of contract, his security deposit will be forfeited, the contract will

be terminated.

4.9 Testing & Reporting Conditions :

4.9.1 On empanelment and entrustment of the job, the Analytical Laboratory

shall furnish the test reports within.

1. 15 days of receipt of the sample in case of all non-sterile

Preparations.

2. 30 days of receipt of the sample in the case of sterile Preparations.

*In case of emergency OSMCL may ask the empaneled laboratory (ies) to

furnish test reports within 7days with additional charges as per price

schedule agreed upon.

4.9.2 All the tests mentioned in IP / BP / USP / BIS / Drugs & Cosmetics Rules.

etc., (as the case may be) should be carried out for each and every

sample. The actual test value obtained after analysis should be clearly

mentioned in the report figures /& words in the report of test / analysis.

Amendments, Addendum, Corrigendum etc published to the reference

monographs shall be taken in to account in the testing parameters time

to time.

[21]

4.9.3 Mentioning the words “COMPLIES” or “PASSES” in the result column of

the report shall be treated as incomplete report. It is essential to express

the value of test results in figures and the value of Standard limits.

4.9.4 Every test report must have remarks (i.e.) Standard Quality or Not of

Standard Quality.

4.9.5 Reports should have Sl. No. Description of test, Specification Results

obtained and the reference monograph.

4.9.6 Protocols of test applied shall be furnished along with the test report

Spectra / Chromatography data sheets, wherever applicable shall also be

furnished.

4.9.7 All test reports should be submitted to the OSMCL in triplicate. In case of

failure of a sample, the result should be communicated immediately to

the Managing Director through Phone / Fax / E-mail and the report

should be sent with protocol.

4.9.8 If under any circumstances (like break down of instrument, non-

availability of reference standard etc.) the Analytical Laboratory is unable

to undertake analysis for samples, the same should be reported within

24 hours of receipt of such samples by FAX or E-mail and the samples

should be returned to the Quality Assurance Section, Odisha State

Medical Corporation Limited.

4.9.9 Every care will be taken for proper packaging of the sample to ensure

safe and intact delivery to the laboratory. If however any sample is

received in a broken condition, then the information should be sent

immediately to the Quality Assurance cell of OSMCL by FAX or E-mail.

4.9.10 In the case of Non-Pharmacopoeial Products the Method of Analysis

adopted should be appended to the Report.

4.9.11 Test Result shall be sent through e-mail followed by signed hardcopies.

[22]

4.9.12 Furnishing of inconsistent / incorrect / unreliable test results for three

times or more during the contract will lead to the termination of contract

of the laboratory and blacklisting for a period up to three years

immediately succeeding the EOI year and the empanelled laboratory will

be ineligible to participate in any of the offers / tenders of the

Corporation for a period of three years.

4.10 Payment Provisions :

4.10.1 No advance payment towards analysis of drugs will be made.

4.10.2 Payments towards the analysis of drugs will be made strictly as per terms

and conditions laid down in the EOI document. All payments will be

made only by way of electronic fund transfer in favor of the laboratory.

4.10.3 All bills / Invoices in triplicate is to be submitted directly to the OSMCL

(QA cell).

4.10.4 If, at any time during the operation of the contract, any new / additional

statutory tax or other levy is impressed to the testing of the drugs and

other items or if the statutory taxes, levies, duties etc. applicable are

increased, the rates agreed upon for testing will also be eligible to be

increased proportionally.

4. 11 Applicable Law &Jurisdiction of Courts :

4. 11.1 The contract shall be governed by and interpreted in accordance with the

laws of India for the time being in force.

4.11.2 Any and all disputes arising out of this EOI/contract will be subject only

to the jurisdiction of courts of law situated in Bhubaneswar city or

normally having territorial jurisdiction over Bhubaneswar city or the High

Court of Odisha as applicable.

[23]

4.12. Corrupt or Fraudulent Practices :

4.12.1 It is required by all offerers/empanelled laboratory to observe the

highest standard of ethics during the process, execution and operation of

the contracts. In pursuance of this policy, the Corporation defines, for the

purpose of this provision, the terms set forth below as follows :

4.12.2 “Corrupt practices” means the offering, giving, receiving or soliciting of

anything of value to influence the action of a public official in the Quality

control process or in contract execution and operation; and

4.12.3 “Fraudulent practices” means a misrepresentation of facts in order to

influence a procurement process or the execution or operation of a

contract to the detriments of the OSMCL and includes collusive practice

among offerers (prior to or after EOI submission) designed to establish

testing fees at artificial non-competitive levels and to deprive the

Corporation of the benefits of fair offer. Such other acts termed as

fraudulent practices elsewhere in this document or any act to deceive

the Corporation or any of its employees or any act adversely affecting or

calculated to affect the normal/proper function or activities of the

Corporation such as delaying of reports, furnishing of incomplete reports

etc. shall also be deemed as fraudulent practices.

4.12.4 No offerer shall contact the Corporation or any of his officers or any

officers of the Government on any matter relating to its offer so as to

influence the selection process for empanelment.Any such act shall also

constitute a fraudulent / corrupt practice and would result in rejection of

the EOI offer.

4.12.5 If it is revealed that the analytical Laboratory is involved in any form of

fraud and collusion with the suppliers of Odisha State Medical

Corporation Ltd, the Analytical laboratory will be blacklisted for a period

of 5 years. The offerer shall also be liable for action under criminal law

and the matter will be notified to the concerned Director of Drugs

Control for penal action against them.

[24]

4.13 Force Majeure :

4.13.1 For purposes of his clause, Force Majeure means an event beyond, the

control of the parties to the contractand not involving the

Empanelledlaboratory fault or negligence and which is not foreseeable

and not brought about at the instance of , the party claiming to be

affected by such event and which has caused the non-performance or

delay in performance. Such events may include, but are not restricted to,

acts of the Corporationeither in its sovereign or contractual capacity,

wars or revolutions, hostility, acts of public enemy, civil commotion,

sabotage, fires, floods, explosions, epidemics, quarantine restrictions,

strikes excluding by its employees, lockouts excluding by the

management, and freight embargoes. Scarcity of reagents, reference

materials and power cut are not considered as force majeure.

4.13.2 If a Force majeure situation arises, the Empanelled laboratory shall

promptly notify the Corporation in writing of such conditions and the

cause thereof within ten days of occurrence of such event. The time for

completing the reporting may be extended by the Corporation at its

discretion for such period as may be considered reasonable.

4.13.3 In case due to Force Majeure event if the Corporation is unable to fulfill

its contractual commitment and responsibility, it will notify the

Empanelled laboratory accordingly and subsequent actions taken on

similar lines described in above sub-paragraphs.

4.14 Procedure for Blacklisting :

4.14.1 For blacklisting a laboratory for defaulted reporting, a registered notice

shall be issued to the laboratory calling for explanation within 15 days

from the date of receipt of notice. On receipt of the explanation from the

Laboratory, OSMCL, may take appropriate action on merits of the case

and impose blacklisting provision to the particular laboratory by passing

appropriate orders.

[25]

4.15 Termination of Contract :

4.15.1 Termination for default:- The Corporation without prejudice to any other

contractual rights and remedies available to it (the EOI Inviting

Authority), may, by written notice of default sent to the successful

offerer (Empanelled laboratory), terminate the contract in whole or in

part, if the successful offerer fails to perform any other contractual

obligation(s) within the time period specified in the contract.

4.15.2 Unless otherwise instructed bythe EOI Inviting Authority, the successful

offerer (Empanelled laboratory) shall continue to perform the contract to

the extent not terminated.

4.15.3 Termination for insolvency: If the successful offererbecomes bankrupt or

otherwise insolvent, the Corporation reserves the right to terminate the

contract at any time, by serving within notice to the successful offerer

without any compensation, whatsoever, to the successful offerer

(Empanelled laboratory), subject to further condition that such

termination will not prejudice or affect the rights and remedies which

have accrued and / or will accrue thereafter to the EOI Inviting Authority.

4.15.4 Termination for convenience: The Corporation reserves the right to

terminate the contract, in whole or in part for its (EOI Inviting

Authority’s) convenience, by serving written notice on the successful

offerer (Empanelled laboratory) at any time during the currency of the

contract. The notice shall specify that the termination is for the

convenience of the EOI Inviting Authority. The notice shall also

indicateinteralia, the extent to which the successful offerers performance

under the contract is terminated, and the date with effect from which

such termination will become effective.

4.15.5 Termination due to change of ownership, constitution, suspension/

cancellation of statutory approval/ certification, accreditation etc.

[26]

4.15.6 Where there is a change of ownership (in the case of sole proprietorship

unit) of the Empanelled laboratory under contract, the contract will

stand automatically terminated. The owner of the Empanelled laboratory

shall inform the change of ownership to the EOI Inviting Authority as

soon as the change takes place. The new owner will be eligible for a fresh

contract for the remaining period of the earlier contract with the former

owner under the same terms and conditions on deposit of the

performance security amount. Inspection of the laboratory will be the

discretion of the EOI Inviting Authority.

4.15.7 Where there is a change of constitution of the firm running the

Empanelled laboratory, the contract will stand terminated from the date

of change of constitution if the person(s) responsible for the firm for the

contract and its day to day operations change. In such an event new firm

will be eligible for further fresh contract from the remaining period of the

earlier contract with the firm under the same terms and conditions. The

performance security deposited earlier may be adjusted for the fresh

contract on mutual agreement.

4.15.8 Where there is temporary or permanent suspension / cancellation /

withdrawal / revoking of the statutory approval / certification /

accreditation on the basis of which the laboratory was empanelled and

contract was awarded, the contract will stand terminated from the date

of such action coming into force. Such termination may, however, be

withdrawn if the action is cancelled or stayed by any competent forum. It

will be onus of the Empanelled laboratory to report any such action

taken against it.

FOR ODISHA STATE MEDICAL CORPORATION LTD.

(MANAGING DIRECTOR)

[27]

ANNEXURE – I

CHECK LIST

Name of the Laboratory : __________________________________

Address : __________________________________

Sl. No. Documents to be submitted Page No.

1

Checklist (Annexure-I) for the list documents enclosed with their

page nos. The documents should be serially numbered and

arranged as per Annexure-I

2

EOI Document Cost in the form of DD shall be kept in an

envelope.

DD No.& date :

Bank & branch :

Amount in Rs :

3

Earnest Money Deposit in the form of DD shall be kept in an

envelope, IF NOT EXEMPTED,

As per clause 4.2.4 valid documentary evidence to prove the

claim.

4

Copy of self-attested Documentary evidence for the constitution

of the company / concern such as Memorandum and Articles of

Association, along with self-attested copies of From 32

wherever there is a change of Directors, Latest Partnership deed

(Self attested copy), Bye law in the case of society, trust etc.

with details of the Name, Address, Telephone number, Fax

number, e-mail address of the firm and of the Managing

Director / Partners / Proprietor / other responsible persons /

office bearers. The list of present MD & Directors of the firm

shall also furnished separately.

5 Annual turnover statement certified by the auditors for last

three years 2011-12, 2012-13, 2013-14(Annexure V).

[28]

6

Self-attested Photocopyof approval for testing of Drugs and the

list of drugs approved for testing in the laboratory issued by the

Drugs Control Authority and valid renewal with list of approved

products for testing.

7 Self-AttestedPhotocopy of valid GLP Certificate issued by the

Drugs Control Authority and valid renewal.

8 Self-attestedPhotocopy of NABL accreditation certificate and its

valid renewal.

9 Self-attested copy of certificate of registration for service tax.

10

Self-attested copies of audited balance Sheet and Profit and

Loss account for the last three years i.e. 2011-2012, 2012-2013,

2013-2014. (Annexure V)

11 The list of qualified personnel employed in the laboratory

(Employees name, Qualification and experience)

12 The list of sophisticated analytical equipments & apparatus

available in the laboratory. (Annexure III)

13 Duly filled performance statement in (AnnexureIV)

14 Declaration in the Proforma given in(Annexure VI)

15 Details of Analytical Laboratory in (Annexure II)

16 List of Drugs and other items for which price quoted by the

lab.(Annexure X)

17 EOI document signed by the offerer in all pages with office seal

18 Self-attested copy of PAN

[29]

ANNEXURE – II

DETAILS OF ANALYTICAL LABORATORY

Sl. No.

Particulars Details (To be filled in by the EOI

Responder)

1 Name of the Organization

2

Address (Regd. Office) : Telephone : Fax : e-mail : website :

3

Address (Laboratory Premises)* Telephone : Fax : e-mail : website :

(* If testing of the items are performed in more than one premises, details of all such units shall be furnished.)

4

Name of the Contact Persons : Designation : Telephone : Mobile : E-mail ID :

5 Type of the Origination (Public Sector / Limited /Private sector / Partnership / Proprietary / Any Other) :

6 Date of the inception of the firm

7

Chief Officer of the Organization : E-mail ID : Telephone :

[30]

8 Registration No. & Date of Incorporation of

Company :

9

License No. issued by the Drugs Control Dept. of the state for conducting the Analysis. Date of issue and correct validity of the licence period shall also be specified.

10 PAN no.

11

List of minimum 3 Clients as per clause No. 3.2.5 (Provide number of samples, type, contract details like Address, Contract Persons, e-mail ID, Telephone)

13

Whether the Licence / Approval / accreditation of the laboratory was cancelled / suspended by the authority in the past, if yes give details.

14

Whether any prosecution action is in progress or pending against the laboratory or any of its management furnish details of past conviction(s) if any.

Date :________________ Authorized Signatory :

Seal

[31]

ANNEXURE – III

LIST OF SOPHISTICATED ANALYTICAL EQUIPMENT & APPARATUS

AVAILBLE IN THE LABORATORY

Name of the laboratory : ___________________

Address : ___________________

Name of the Equipment/ Instruments/ Apparatus

Name & Description

Date of Installation

Working Conditions

FACILITIES IN THE MICROBIOLOGICAL SECTION

List of Equipments / Apparatus Available with Date Installation (eg. Incubators, Autoclave etc.)

Date :______________ Authorized Signatory :

Seal :

[32]

ANNEXURE – IV

PROFORMA FOR PERFORMANCE STATEMENT

(For a period of last 3 years)

Name of the laboratory : _____________________

Address : _____________________

Type of Sample Analyzed No. of Sample Analyzed during

2011-12 2012-13 2013-14

1 Tablets / Capsules

2 Inject able

3 Liquid Orals

4 Ointments / Creams / Gels

5 Surgical (Specify types)

6 Sutures (Specify types)

7 Other Categories (Specify)

8 Other Category (Specify)

Signature :

Date :

Name of the Lab :

Office Seal :

[33]

ANNEXURE – V

ANNUAL TURNOVER STATEMENT

I hereby certify that M/s _____________________________________

(Name & address _________________________________) who is participating in

the EOI No. OSMCL/QA/EOI/01/2015-16 of OSMCL is having the following annual

turnover and the statement is true and correct.

Sl. No. Year Turnover (Rs.)

1 2011 – 2012

2 2012 – 2013

3 2013 - 2014

Total (Rs.)

Average turnover per annum (Rs.)

Date : Signature of Auditor/ Chartered Accountant

Reg. No. :

Seal :

[34]

ANNEXURE-VI

DECLARATION

I / We ________________________________________________ (Name of the Laboratory)

having office at ______________________________________________________________

___________________________________________________________________________

___________________________________________________________________________

_______________________ Laboratory at ________________________________________

________________________ do declare that I / We have carefully read all the conditions of

EOI No. OSMCL/QA/01/2015-16 of Odisha State Medical Corporation Ltd., Bhubaneswar,

for the EOI floated for empanelment of analytical testing laboratories for the analysis of

drugs and supplies, for a period of two years from the date of acceptance and abide by all

conditions set forth therein. I / We do accept all the terms and conditions of the above EOI

document including amendments of the tender, if any published by the Corporation.

Signature :

Date :

Name of the lab :

Office Seal :

[35]

ANNEXURE-VII

FORMAT OF BANK GUARANTEE FOR SECURITY DEPOSIT

To

The Odisha State medical Corporation Limited, Covent Square, Bhubaneswar – 751007

WHERAS ____________________________ (Name and address of the Laboratory) has

undertaken, in pursuance of contract no _________________________ dated

__________________ (herein after called “the contract”) to conduct quality control analysis

for Odisha State Medical Corporation Ltd.

AND WHEREAS it has been stipulated by you in the contract that the laboratory shall

furnish you with a bank guarantee by a scheduled commercial bank recognized by you for

the sum specified their in as security for compliance with its obligations in accordance with

the contract;

AND WHEREAS we have agreed to give the laboratory such a bank guarantee;

NOW THEREFORE we affirm that we are guarantors and responsible to you on behalf

of the Laboratory, up to a total amount of ____________________ (Amount of the

guarantee in words and figures), and we undertake to pay you, upon your first written

demand declaring the laboratory to be in default under the contract and without cavil or

argument, any sum or sums within the limits of (amount of guarantee) as aforesaid, without

your needing to provide or to show grounds or reasons for your demand or the sum

specified therein.

We hereby waive the necessity of your demanding the said debt from the laboratory

before presenting us with the demand.

[36]

We undertake to pay you any money so demanded notwithstanding any dispute or

disputes raised by the laboratory (s) in any suit or proceeding pending before any Court or

Tribunal relating thereto liability under these presents being absolute and unequivocal.

We agree that no change or addition to or other modification of the terms of the

contract to be performed there under or of any of the contract documents which may be

made between you and the laboratory shall in any way release us from any liability under

this guarantee and we waive notice of any such change, addition or modification.

No action, event or condition that by any applicable law should operate to discharge

us from liability, hereunder shall have any effect and we hereby waive any right we have to

apply such law, so that in all respects our liability hereunder shall be irrevocable and expect

as stated herein, unconditional in all respects.

This guarantee will not be discharged due to the change in the constitution of the

Bank or the Laboratory (s).

We, __________________________________ (indicate the name of bank) lastly

undertake not to revoke this guarantee during its currency except with the previous

consent, in writing, of the Odisha State Medical Corporation Ltd.

This Guarantee will remain in force up to ___________ (Date). Unless a claim or a

demand in writing is made against the bank in terms of this guarantee on or before the

expiry of __________ (Date) all your right in the said guarantee shall be forfeited and we

shall be relieved and discharged from all the liability there under irrespective of whether

the original guarantee is received by us or not.

(Signature with date of the authorized officer of the Bank)

……………………………………………………………………………..…………..

Name and designation of the officer

………………………………………………………………………………………....

………………………………………………………………………………………….

Seal, name & address of the Bank and address of the Branch

[37]

ANNEXURE-VIII

AGREEMENT

This agreement made on this …………………… day of …………………..20………….between

……………………… Odisha State Medical Corporation Ltd. by its Managing Director (Expression

of Interest (EOI) Inviting Authority) having its registered office at Bhubaneswar (hereinafter

mentioned as “The OSMCL” or the corporation of one part and M/s.

………………………………………………………………………………………………………………………………………………

…………………………………………………………………………………………………..(Name and Address or the

laboratory) (hereinafter called as the Empanelled laboratory or the “Laboratory “ in short)

represented by …………………………………………………………………….. (Name of the authorized

signatory and Designation) agreed …………………. Years, residing at

……………………………………………………… (Full residential address of the signatory) of the other

part.

WHERE as the OSMCL had invited Expression of Interest (EOI) from eligible Analytical

Laboratory for test and analysis of Drugs and other consumables procured by it for supply

to the healthcare institution under the Health & Family Welfare

Department of Odisha as per the EOI document number ………….. dated ………… and had

prescribed eligible criteria and various terms and condition for participation and

presentation of the EOI, and

The Empanelled Laboratory above has offered to the Odisha State Medical

Corporation Ltd. to undertake analytical work of the list of items mentioned in the

Annexure attached hereto, in according with the terms and conditions specified in the

above said EOI document, at the rates noted therein and had given an undertaking in

writing to those effects and in the manner and under the terms and conditions hereinafter

mentioned, and

The EOI Inviting Authority (OSMCL) has accepted the offer, and

The Empanelled laboratory has deposited with the OSMCL a sum of Rs. ……………………

(Rupees………………………………………………..….) as security Deposit for the due and faithful

performance of this Agreement and liable to be forfeited as liquidated damages in the

event of the Laboratory failing duly and faithfully to perform its obligations set forth

hereinafter.

[38]

In this agreement words and expressions shall have the same meanings as are

respectively assigned to them in the EOI document referred to .

Now therefore these present witness that for carrying out the said agreement in this

behalf execution, the Empanelled laboratory and the OSMCL do hereby mutually covenant,

declare and agree each of them with the other in the manner following, that is to say,

1. The term “Agreement” wherever used in this connection, shall mean the terms and

condition stipulated hereinafter for the analysis of Drugs, surgical and other items

for the year 2015 – 2016 & 2016 – 2017.

2.

(a) The agreement is for undertaking analysis of Drugs Surgical items & sutures

item by the Empanelled Laboratory to the Odisha State Medical Corporation

Ltd, of the samples specified in the ………………….. (will specify later ) attached

hereto at the rates noted against each therein on the terms and conditions set

forth in this agreement and strictly within the time frame stipulated for the

respective items in clause 3.1 of the EOI document.

(b) This agreement shall be deemed to have come into with effect from --------------

(Date of execution of agreement) and it shall remain in force for a period of

two years with effect from that date and may however be extended for a

further period, on mutually agreed terms signed by both parties.

(c) The time frame specified in clause 3.1 of the EOI document for the respective

item shall be strictly adhered to by the Laboratory. Testsand Analysis of drugs

and other items will be performed in accordance with the statutory standards

such as IP,BP,USP,BIS, etc. and in the case of item for which no officials

standards, by applying such recognized or prescribed or authentic parameters

of standards quality and the test reports shall reach the OSMCL within the

maximum time limit specified in the EOI document reckoned from the date on

which the item to be tested is delivered to the Empanelled Laboratory, failing

which the measures of penalty and others specified will be applicable.

(d) The test reports are to be submitted to the OSMCL by email within the time

period specified in clause 3.1 of the EOI document at the email address of the

OSMCL ‘qaosmcl.od@nic.in’ to be followed by three sets of hardcopies duly

authenticated.

(e) In the event of any failure / default / deviations from EOI agreement on the

part of the Empanelled laboratory with any qualification loss to the OSMCL, the

amount of the performance security is liable to be forfeited. If the empanelled

laboratory withdraws from the contract during the period of contract, the

[39]

security deposit shall be liable to be forfeited the contract terminated and the

empanelled laboratory shall be liable to be blacklisted for a period of three

years immediately succeeding the EOI year making them ineligible to

participate in any of the offers/ tender of the Corporation.

3. In respect of the analysis of items in the Scheduled the laboratory shall allow

inspection of the laboratory at any time during the continuance of the contract

period by a team of Experts/Officials whom the OSMCL may depute for the purpose.

The laboratory shall extend all instruments, all relevant records, analysis etc., in the

Empanelled Laboratory and also to take photographs of such facilities, which shall

not be used by the Corporation other than pursuance of actions under the terms and

conditions of this contract and also the EOI document.

4. All expenses, damages and other moneys payable to the OSMCL by the Empanelled

Laboratory under any provisions of this Agreement may be recovered from the

amount due or subsequently becoming due from the OSMCL to the laboratory under

this or any other agreement. In case such amount are insufficient to fully cover such

expenses, damages or other moneys payable. It shall be lawful for the OSMCL to

recover the balance amount from the security deposit of the laboratory and all other

money held by OSMCL and in case such security deposit is insufficient them it shall

be also be lawful for the OSMCL to recover the residue of the expenses, damages

and moneys if necessary by means of legal proceeding against the Empanelled

Laboratory.

5. The amount of security deposit remitted by the laboratory to the OSMCL by way of

Demand Draft by favouring the Odisha State Medical Corporation Ltd, Bhubaneswar

will be returned on successful fulfillment of the terms and conditions of this

agreement without interest.

6.

(a) No advance toward any analysis will be made to the Empanelled Laboratory.

(b) All bills/invoices should be raised in triplicate in the name of the managing

director OSMCL. All payments will be made only by way of electronic fund

transfer in favour of the empanelled laboratory for which bank details shall be

furnished to the corporation at time of entering into agreement.

(c) The empanelled laboratory shall furnish the last reports within:

I. 15 days of receipt of the samples in case of Tablets, Capsules, Pessaries,

Ointments, Powder’s and Liquid Oral Preparation, and

II. 30 days of receipt of the samples in the case of all other sterile

preparations.

[40]

III. 7 days of receipt of non-sterile preparation in case of immergence with

additinal charges as per price schedule agreed upon.

(d) If a laboratory fails to submit the report of analysis within the above stipulated

period penalty of 0.5% per day of the delayed reporting up to a maximum of

10% on the value of testing will be levied.

7. The empanelled laboratory shall not at anything assign, sub-let or make over the

present contract or the benefits thereof or any part thereof, to any person or

persons whomsoever.

8. The following document shall be deemed to form and be read and construed as part

of this agreement, viz.:

(a) All the documents submitted by the empanelled laboratory as a part of the EOI

offer,

(b) The Schedule of Requirements;

(c) The Specifications and other quality parameters;

(d) All the clarifications and amendments issued / received as part of the EOI

Documents

(e) All correspondence as part of tender during or after the date of agreement

accepted by Tender Inviting Authority

9. The terms and conditions specified in the EOI documents published by the EOI

Inviting Authority in acceptance of which the empanelled laboratory had presented

the EOI offer will apply in matters not specifically in this agreement.

10. The Empanelled Laboratory and the Corporation mutually agree that any and all

disputes arising out of this Agreement will be subject only to the jurisdiction of

courts of law/tribunals situated in Bhubaneswar city or normally having territorial

jurisdiction over Bhubaneswar city only or the High Court of Odisha a applicable and

the provisions of clause 4.12 of the EOI document are agreed to in full.

In witness whereof the parties hereto have caused this Agreement to be executed in

accordance with their respective laws the day year first above written.

[41]

Signed, Sealed and Delivered by the

Said …………………………………………………………. (For the EOI Inviting Authority – OSMCL)

In the presence of,

1……………………………………………………………….. (Signature, name and Address)

2……………………………………………………………….. (Signature, name and Address)

Signed, Sealed and Delivered by the

Said ……………………………………………………….… (For the EOI Inviting Authority – OSMCL)

In the presence of,

1………………………………………………………..……… (Signature, name and Address)

2……………………………………………………………..… (Signature, name and Address)

[42]

ANNEXURE-IX

List ofDrugs and other items to be offered for test and analysis

ODISHA STATE MEDICAL CORPORATION LTD. BHUBANESWAR- 751007

Tender for Empanelment of Analytical Testing Laboratories for the Analysis of Drugs and Medicines for the year 2014-2015

Sl. No. Drug code

GENERIC NAME OF THE MEDICINES QUOTED BY LAB AS

SYMBOLE (√) OR YES

1 D01019 Inj. Etomidate

2 D01005 Halothane

3 D01020 Isoflurane

4 D01021 Isoflurane

5 D01001 Inj. Ketamine HCl I.P

6 D01022 Inj. Propofol I.P (1%)

7 D01023 Sevoflurane

8 D01024 Sevoflurane

9 D01002 Inj. Thiopentone Sodium I.P

10 D02006 Inj. Bupivacaine I.P

11 D02008 Inj. Bupivacaine (Heavy)

12 D02009 Inj. Levobupivacaine

13 D02007 Lidocaine Hydrochloride gel 2% I.P

14 D02001 Inj. Lignocaine HCl I.P.

15 D02003 Inj. Lignocaine HCl and AdrenalineBitartrate I.P

16 D02005 Inj. Lignocaine HCl and Dextrose I.P. (Heavy)

17 D02010 Inj. Ropivacaine Hydrochloride

18 D03005 Inj. Dexmedetomidine

19 D03002 Inj. Glycopyrrolate

20 D01007 Inj. Midazolam I.P.

21 D01008 Inj. Atracurium Besylate I.P.

22 D17047 Inj. Ephedrine HCl I.P.

23 D24006 Inj. Neostigmine MethylsulphateI.P.

[43]

24 D24008 Inj. Neostigmine Methylsulphate +Glycopyrrolate

25 D24009 Tab. Pyridostigmine I.P.

26 D24010 Inj. Rocuronium Bromide

27 D24011 Inj. Succinyl Choline Chloride I.P.

28 D24005 Inj. Vecuronium Bromide

29 D04025 Tab. Aceclofenac I.P.

30 D04009 Tab. Diclofenac Sodium I.P (Coated)

31

D04010 Inj. Diclofenac SodiumAquous Preparation I.P

32 D04005 Tab. Ibuprofen I.P (Coated)

33 D04032 Susp. Ibuprofen

34 D04044 Tab. Mephenamic Acid (Disp. Tab.)

35 D04003 Syp. Paracetamol I.P

36 D04026 Paracetamol Drop

37 D04033 Inj. Paracetamol I.V

38 D04022 Tab. Paracetamol Kid (Disp. Tab.)

39 D04043 Tab. Paracetamol Kid (Scored Disp. Tab.)

40 D04002 Tab. Paracetamol I.P

41 D04045 Paracetamol Rectal Suppository

42 D04028 Tab. Codeine Phosphate I.P

43 D04046 Inj. Fentanyl Citrate I.P

44 D04011 Inj. Morphine Sulphate I.P

45 D04047 Tab. Morphine Sulphate I.P

46 D04008 Inj. Pentazocine Lactate I.P

47 D04029 Inj. Pethidine Hydrochloride I.P

48 D04021 Inj. Tramadol HCl

49 D04048 Tab. Tramadol Hydrochloride (Coated)

50 D33068 Tab. Azathioprine I.P

51 D33069 Tab. Hydroxy Chloroquine I.P

52 D33009 Tab. Methotrexate I.P (coated)

53 D05017 Inj. Betamethasone Sod. PhosphateI.P

54 D05011 Syp. Cetirizine Dihydrochloride I.P

[44]

55 D05010 Tab. Cetirizine Dihydrochloride I.P

56 D05006 Tab. Chlorpheniramine Maleate I.P

57 D05001 Inj. Dexamethasone Sodium Phosphate I.P

58 D05019 Tab. Dexamethasone I.P

59 D05022 Tab. Dexamethasone I.P

60 D05002 Inj. Hydrocortisone Sodium Succinate I.P

61 D05021 Tab. Levocetirizine Dihydrochloride I.P

62 D05023 Inj. Methylprednisolone I.P

63 D05024 Tab. Methylprednisolone I.P

64 D05025 Inj. Noradrenaline I.P

65 D05007 Inj. Pheniramine Maleate I.P

66 D05015 Tab. Prednisolone I.P

67 D33022 Syp. Prednisolone

68 D06004 Inj. Acetylcysteine

69 D06005 Tab. Activated Charcoal

70 D06006 Inj. Atropine I.V

71 D03001 Inj. Atropine Sulphate I.P

72 D06001 Inj. Dimercaprol I.P

73 D06007 Inj. Methylene Blue

74 D03003 Inj. Naloxone HCl I.P

75 D03004 Potassium Permanganate I.P

76 D06002 Inj. Pralidoxime Chloride / Iodide I.P

78 D06008 Inj. Sodium Nitrite

79 D06009 Inj. Sodium Thiosulfate I.P

80 D07003 Tab. Carbamazepine I.P(Controlled Release)

81 D07015 Tab. Carbamazepine I.P (Controlled Release)

82 D07016 Tab. Clobazam Capsule I.P

83 D07013 Inj. Fosphenytoin Sodium

84 D07010 Inj. Lorazepam I.P

85 D07017 Tab. Pramipexole

86 D07002 Inj. Phenobarbitone I.P

[45]

87 D07011 Phenobarbitone Oral Solution

88 D07001 Tab. Phenobarbitone I.P

89 D07007 Inj. Phenytoin Sodium I.P

90 D07018 Tab. Phenytoin Sodium I.P

91 D07019 Inj. Levetiracetam

92 D07020 Tab. Levetiracetam

93 D07012 Elixir Sodium Valproate I.P

94 D07021 Inj. Sodium Valproate I.P

95 D07022 Tab. Sodium Valproate (Controlled Release) (Enteric Coated)

96 D07005 Tab. Sodium Valproate (Controlled Release) (Enteric coated) I.P

97 D27093 Tab. Levodopa + Carbidopa I.P

98 D27060 Tab. Trihexyphenidyl I.P

99 D08004 Tab. Albendazole I.P(Chewable)

100 D08003 Susp. Albendazole I.P

101 D08008 Tab. Ivermectin

102 D08001 Tab. Mebendazole I.P

103 D09019 Inj. Amikacin Sulphate

104 D09101 Inj. Amoxycillin Trihydrate I.P

105 D09111 Tab. Amoxycillin Trihydrate I.P (Dispersible Tablet)

106 D09050 Cap. Amoxycillin Trihydrate I.P

107 D09060 Amoxycillin oral suspension I.P

108 D09004 Inj. Ampicillin Sodium I.P

109 D09089 Susp. Azithromycin

110 D09095 Azithromycin Oral Suspension

111 D09077 Tab. Azithromycin

112 D09006 Inj. Benzathine Penicillin I.P

113 D09051 Tab. CefadroxilI.P (Dispersible Tablet)

114 D09104 Cefadroxil Drop

115 D09026 Tab. Cefadroxil I.P

116 D09129 Inj. Cefepime I.P

[46]

117 D09096 Tab. Cefixime I.P Dispersible

118 D09091 Tab. Cefixime I.P

119 D09131 Inj. Cefoperazone & Sulbactam

120 D09132 Inj. Cefoperazone I.P

121 D09053 Inj. Cefotaxime Sodium I.P

122 D09119 Inj. Ceftazidime I.P

123 D09093 Inj. Ceftriaxone I.P

124 D09061 Inj. Chloramphenicol

125 D09020 Tab. Ciprofloxacin HCl I.P

126 D09007 Inj. Ciprofloxacin I.V. I.P

127 D09133 Tab. Clarithromycin I.P

128 D09003 Susp. Cotrimoxazole I.P

129 D09065 Tab. Cotrimoxazole Kid (Disp. Tab.)

130 D09110 Tab. Cotrimoxazole Paediatric I.P

131 D09002 Tab. Cotrimoxazole I.P

132 D09015 Cap. Doxycycline HCl I.P

133 D09016 Tab. Erythromycin Stearate I.P

134 D09010 Inj. Gentamicin Sulphate I.P

135 D09121 Inj. Linezolid I.V I.P

136 D09122 Tab. Linezolid I.P

137 D09135 Susp. Linezolid

138 D09124 Tab. Levofloxacin I.P

139 D09136 Inj. Meropenem I.P

140 D09137 Tab. Moxifloxacin

141 D09100 Tab. Nitrofurantoin I.P

142 D09017 Tab. Norfloxacin I.P

143 D09066 Tab. Norfloxacin (DispersibleTablet)

144 D09138 Susp. Ofloxacin I.P

145 D09033 Tab. Ofloxacin (DispersibleTablet)

146 D09073 Inj. Ofloxacin I.V I.P

147 D09139 Tab. Ofloxacin I.P

[47]

148 D09140 Tab. Penicillin G Potassium

149 D09087 Inj. Piperacillin + Tazobactam

150 D09141 Inj. Teicoplanin

151 D09070 Cap. Tetracycline I.P

152 D09120 Inj. Tobramycin I.P

153 D09106 Inj. Vancomycin I.P

154 D10002 Cap. Clofazimine I.P

155 D10001 Tab. Dapsone I.P

156 D11022 Inj. Capreomycin I.P

157 D11023 Cap. Cycloserine I.P

158 D11007 Tab. Ethambutol (coated)

159 D11024 Tab. Ethionamide I.P

160 D11004 Tab. INH I.P (Coated)

161 D11025 Inj. Kanamycin I.P

162 D11010 Tab. Pyrazinamide I.P (Coated)

163 D11009 Susp. Rifampicin I.P

164 D11002 Tab./Cap. Rifampicin I.P

165 D11027 Sodium PAS I.P

166 D11001 Inj. Streptomycin Sulphate I.P

167 D11029 Tab. Thiacetazone

168 D12018 Inj. Amphotericine B I.P

169 D12012 Clotrimazole Lotion

170 D12009 Clotrimazole Vaginal Pessaries I.P

171 D12007 Tab. Fluconazole (Dispersible Tab.)

172 D12019 Fluconazole Infusion

173 D12008 Tab. Fluconazole

174 D12020 Cream Terbinafine

175 D13005 Tab. Metronidazole I.P (Coated)

176 D13007 Susp. Metronidazole I.P (Oral Susp.)

177 D13003 Inj. Metronidazole I.V I.P

178 D13008 Tab. Ornidazole I.P (Coated)

[48]

179 D13011 Ornidazole Infusion I.P

180 D13002 Susp. Tinidazole (Oral Susp.)

181 D14018 Inj. Artesunate

182 D14001 Tab. Chloroquin Phosphate I.P (Coated)

183 D14002 Syp. Chloroquin Phosphate I.P

184 D14034 Tab. Primaquin Phosphate I.P (coated)

185 D14005 Inj. Quinine Di-Hydrochloride I.P

186 D14004 Tab. Quinine Sulphate I.P (coated)

187 D14010 Susp. Quinine Sulphate I.P

188 D09043 Syp. Diethylcarbamazine Citrate I.P

189 D09092 Tab. Diethylcarbamazine Citrate I.P (Coated)

190 D32007 Tab. Efavirenz I.P

191 D32006 Cap. Indinavir I.P

192 D32021 Lamivudine Oral Solution I.P

193 D32002 Tab. Lamivudine I.P

194 D32022 Nevirapine Oral Suspension I.P

195 D32003 Tab. Nevirapine I.P

196 D32023 Stavudine Oral Solution I.P

197 D32005 Cap. Stavudine I.P

198 D32020 Zidovudine Oral Solution I.P

199 D32001 Tab. Zidovudine I.P

200 D18016 Tab. Acyclovir

201 D18028 Inj. Acyclovir

202 D18029 Tab. Entecavir

203 D33057 Inj. 5 Fluorouracil I.P

204 D33063 Tab. 6 - Mercaptopurine I.P

205 D33062 Inj. Actinomycin D

206 D33048 Tab. Allopurinol I.P

207 D33065 Inj. Arabinocide

208 D33069 Inj. Bleomycin I.P

209 D33045 Tab. Busulfan I.P (coated)

[49]

210 D33055 Inj. Carboplatin I.P

211 D33024 Inj. Cisplatin I.P

212 D33002 Inj. Cyclophosphamide

213 D33064 Inj. Daunorubicin I.P

214 D33015 Inj. Doxorubicin HCl I.P

215 D33061 Inj. Epirubicin I.P

216 D33035 Tab./Cap. Etoposide I.P

117 D33071 Inj. Etoposide I.P

218 D33012 Inj. Fluorouracil I.P

219 D33072 Inj. Gemciatabine I.P

220 D33074 Inj. Ifosfamide

221 D33075 Tab. Imatinib I.P

222 D33053 Inj. L-Asperginase

223 D33011 Inj. Methotrexate I.P

224 D33079 Inj. Paclitaxel I.P

225 D33032 Inj. Vinblastine I.P

226 D33017 Inj. Vincristine Sulphate I.P

227 D16026 Inj. Antithymocyte Globuline(Equine)

228 D16023 Tab. Deferasirox

229 D16017 Tab. Doxylamine Succinate + Pyridoxine

230 D16036 Inj. Enoxaparin I.P

231 D16007 Inj. Ethamsylate

232 D16028 Tab. Ethamsylate

233 D16034 Inj. Human coagulation Factor IX I.P

234 D16032 Inj. Human coagulation Factor VIII I.P

235 D16037 Tab. Ferrous Sulphate + Folic Acid

236 D16031 Syp. Ferrous Sulphate + Folic Acid(Palatable with dropper and plastic container as per I.P, Auto- dispensing bottle)

237 D16011 Syp. Ferrous Sulphate + Folic Acid I.P

238 D16002 Tab. Folic Acid I.P

239 D16004 Inj. Heparin Sodium I.P

[50]

240 D16014 Inj. Hydroxocobalamine I.P

241 D16015 Cap. Hydroxyurea

242 D16016 Tab./Cap. Hydroxyurea

243 D16020 Tab. Iron (Sugar Coated)

244 D16019 Iron drop(Palatable, with dropper and plastic container as per I.P)

245 D16018 Inj. Iron Sucrose

246 D16021 Syp. Iron

247 D30021 Inj. Kenandione (Vit. K)

248 D30030 Tab. Kenandione (Vit. K)

249 D16005 Inj. Menadione (Vit-K3)

250 D16027 Solution Disodium Hydrogen Citrate

251 D16012 Inj. Tranexamic Acid I.P

252 D16013 Tab. Tranexamic Acid I.P

253 D16039 Inj. Vassopressin I.P

254 D20002 Inj. Frusemide I.P

255 D20001 Tab. Frusemide I.P

256 D17026 Tab. Hydrochlorothiazide I.P

257 D20004 Inj. Mannitol I.V I.P

258 D20005 Tab. Spironolactone I.P

259 D17048 Tab. Clopidogrel I.P

260 D17018 Inj. Glyceryl Trinitrate I.P

261 D17001 Tab. Isosorbide Dinitrate I.P

262 D17015 Tab. Amlodipine Besylate I.P

263 D17006 Tab. Atenolol I.P

264 D17049 Tab. Enalapril Maleate I.P

265 D17050 Inj. Esmolol Hydrochloride

266 D17030 Inj. Hydralazine I.P

267 D17033 Tab. Hydralazine

268 D17043 Inj. Labetalol I.P

269 D17042 Tab. Labetalol I.P

270 D17051 Tab. Losartan Potassium I.P

[51]

271 D17020 Tab. Methyl Dopa I.P (coated)

272 D17007 Tab. Metoprolol Tartarate ER

273 D17037 Tab. Metoprolol Tartarate I.P

274 D17016 Cap. Nifedipine I.P (Soft gelatin capsule)

275 D17052 Tab. Nifedipine Sustained Release I.P (SR)

276 D17053 Tab. Ramipril I.P

278 D17032 Tab. Telmisartan

279 D17054 Inj. Adenosine I.P

280 D17038 Tab. Amiodarone B.P

281 D17055 Tab. Carvedilol I.P

282 D17027 Tab. Digoxin I.P

283 D17034 Syp. Digoxin

284 D17040 Inj. Dobutamine HCl

285 D17013 Inj. Dopamine HCl (Intravienous infusion I.P )

286 D17029 Inj. Mephenteramine Sulphate I.P

287 D17041 Inj. Potassium Chloride I.P

288 D17056 Inj. Verapamil I.P

289 D17057 Tab. Verapamil IP

290 D17024 Tab. Aspirin I.P (Coated)

291 D17058 Tab. Aspirin I.P (Enteric Coated)

292 D17025 Inj. Streptokinase I.P

293 D17080 Tab. Atorvastatin I.P

294 D17082 Tab. Fenofibrate

295 D18028 Clindamycin Cream

296 D18029 Clobetasol Dipropionate Ointment I.P

297 D18021 Clotrimazole Mouth Paint

298 D18030 Cream Clotrimazole I.P

299 D18031 Cream Fluocinolone Acetonide I.P

300 D18003 Cream Silver Sulphadiazine I.P

301 D18002 Gamma Benzene Hexa Chloride + Cetrimide

302 D18019 Lotion Fluocinolone Acetonide

[52]

303 D18011 Lotion Permethrin

304 D18032 Mupirocin Ointment I.P

305 D18033 Oint Betamethasone Valerate

306 D18007 Povidone Iodine Solution I.P

307 D19008 Chloroxylenol Solution I.P

308 D19005 Lysol Solution I.P (Cresol With Soap)

309 D19013 Oint Nitrofurazone (Polyglycol Base)

310 D18024 Povidone Iodine Oint.

311 D19004 Soln. Cetrimide

312 D19009 Soln. Chlorohexidine Gluconate + Cetrimide + Isopropyl Alcohol I.P

313 D19007 Soln. Formaldehyde

314 D19006 Surgical Spirit I.P

315 D21003 Tab. Antacid (Dried Aluminium` Hydroxide gel I.P 250 mg. + Magnesium Hydroxide I.P 250 mg. + Methyl Polysiloxane 50 mg.)

316 D21035 Susp. / Gel Antacid Magaldrate 400 mg. + Simethicone 20 mg.) / 5 ml.

317 D21028 Dicyclomine Drop

318 D21013 Inj. Dicyclomine HCl I.P

319 D21011 Tab. Dicyclomine HCl I.P

320 D21014 Syp. Dicyclomine

321 D21010 Tab. Domperidone I.P

322 D21020 Susp. Domperidone I.P

323 D21036 Inj. Drotaverine

324 D21032 Tab. Drotaverine HCl I.P

325 D21031 Tab. Levosulpiride

326 D21004 Inj. Metoclopramide I.P

327 D21009 Cap./Tab. Omeprazole I.P

328 D21039 Inj. Ondansetron I.P

329 D21024 Tab. Ondansetron I.P (Dispersible Tablet)

330 D21038 Syp. Ondansetron I.P

331 D21012 Oral Rehydration salt I.P

332 D21018 Tab. Pantoprazole I.P

[53]

333 D21030 Inj. Pantoprazole

334 D21006 Syp. Promethazine I.P

335 D21005 Inj. Promethazine HCl I.P

336 D21037 Tab. Promethazine I.P

337 D21026 Tab. Rabeprazole I.P (Entric coated)

338 D21025 Inj. Rabeprazole (I.V)

339 D21002 Tab. Ranitidine I.P (coated)

340 D21001 Inj. Ranitidine HCl I.P

341 D21021 Susp. Sucralfate

342 D22013 Tab. Gliclazide

343 D22014 Tab. Glimepiride I.P

344 D22004 Tab. Glipizide I.P

345 D22012 Inj. Human Premixed Insulin(30/70)

346 D22009 Inj. Human Premixed Insulin(50/50)

347 D22002 Inj. Human Soluble Insulin I.P

348 D22010 Tab. Levo Thyroxin Sodium

349 D22003 Tab. Metformin HCl IP (coated)

350 D22016 Tab. Voglibose I.P

351 D23009 Inj. Rabies Vaccine, Human I.P

352 D23012 Inj. Tetanus Immunoglobulin I.P

353 D23010 Inj. Equine Rabies Immunoglobulin I.P

354 D23015 Inj. Hepatitis B Immunoglobulin I.P (HBIG)

355 D23011 Inj. Human Anti-D Immunoglobuline

356 D23014 Inj. Human Rabies Immunoglobuline

357 D23008 Inj. Snake Venom Antiserum I.P (Polyvalent) liquid form

358 D23002 Inj. Snake Venom Antiserum I.P (Polyvalent) lyophilized power form

359 D23005 Inj. Tetanus Vaccine (adsorbed) I.P.

360 D25029 Bimatoprost Eye Drop

361 D25011 Chloromycetin Eye Ointment (Applicap/Soft Capsule)

362 D25012 Ciprofloxacin Eye /Ear Drop I.P

[54]

363 D25022 Clotrimazole & Lignocaine Ear Drop

364 D25021 Fluorescein Sodium Eye Drop I.P

365 D25001 Gentamicin Sulphate Eye /Ear Drop I.P

366 D25025 Homatropine Eye Drop I.P

367 D25026 Lidocaine + Ofloxacin Ear Drop

368 D25023 Ofloxacin Ophthalmic Solution I.P

369 D25027 Phenylepherine Eye Drop

370 D29015 Saline Nasal Drop

371 D25028 Timolol Eye Drop I.P

372 D25024 Tropicamide + Phenylephrine Eye Drop

373 D26005 Inj. Carboprost Tromethamine I.P

374 D26014 Dinoprostone Gel

375 D26013 Inj. Ethacridine Lactate

376 D26009 Inj. Hydroxy Progestrone I.P

377 D26011 Inj. Isoxsuprine HCl I.P

378 D26015 Tab. Isoxsuprine SR I.P

379 D26004 Tab. Isoxsuprine I.P

380 D26006 Inj. Magnesium Sulphate I.P

381 D26001 Inj. Methylergometrine Maleate I.P

382 D26003 Tab. Methylergometrine Maleate I.P

383 D26016 Inj. Micronised Progesteron

384 D26017 Cap. Micronised Progesteron

385 D26012 Tab. Mifepristone I.P

386 D26007 Tab. Misoprostol I.P

387 D26008 Tab. Norethisterone Acetate I.P

388 D26002 Inj. Oxytocin I.P

389 D27028 Tab. Amitriptyline + Chlordiazepoxide

390 D27030 Tab. Chlorpromazine + Thrihexyphenidyl

391 D27014 Tab. Clonazepam I.P

392 D27031 Tab. Clozapine I.P

393 D07006 Inj. Diazepam I.P

[55]

394 D27001 Tab. Diazepam I.P

395 D27076 Tab. Disulfiram I.P

396 D27034 Tab. Divalproex Sodium I.P

397 D27068 Tab. Donepezil I.P

398 D27037 Tab. Escitalopram

399 D27017 Tab. Fluoxetine

400 D27012 Inj. Haloperidol I.P

401 D27006 Tab. Haloperidol I.P

402 D27020 Inj. Haloperidol Decanoate

403 D27043 Tab. Lithium Carbonate I.P

404 D27013 Tab. Lorazepam I.P

405 D27025 Inj. Olanzapine

406 D27046 Tab. Olanzapine I.P

407 D27052 Tab. Procyclidine I.P

408 D27015 Tab. Resperidone

409 D27056 Tab. Sertraline I.P

410 D27058 Tab. Sodi-Valporate CR

411 D27094 Tab. Thrihexyphenidyl

412 D27010 Tab. Thioridazine

413 D28014 Beclomethasone Inhaler I.P

414 D28019 Budesonide Inhaler

415 D28017 Tab. Doxofylline I.P

416 D28020 Respules Salbutamol B.P

417 D28022 Respules Salbutamol + Ipratropium

418 D28013 Salbutamol Inhaler I.P

419 D28018 Soln. Salbutamol Sulphate

420 D28004 Tab. Salbutamol Sulphate I.P

421 D28011 Syp. Salbutamol Sulphate I.P

422 D28001 Inj. Theophylline & Etophylline

423 D28003 Tab. Theophylline & Etophylline

424 D29003 I.V Compound Sodium Lactate Inj. I.P (Ringer's Lactate)

[56]

425 D29005 I.V Dextrose 10% I.P (10D)

426 D29004 I.V Dextrose 5% I.P(5D)

427 D29014 I.V Dextrose 25% I.P (D25)

428 D29002 I.V Dextrose and Sodium Chloride Inj. I.P

(DNS)

429 D29013 Inj. Calcium Gluconate I.P

430 D29016 Multi Electrolyte Infusion

431 D29006 Oral Soln. of Potassium Chloride

432 D29011 Inj. Pottasium Chloride I.P

433 D29009 Paediatric Maintenance Fluid

434 D29017 Hydroxy Ethyl Starch 6%

435 D29008 Inj. Sodium Bi-Carbonate I.P

436 D29012 Inj. Sodium Chloride I.P (NormalSaline) 0.9% W/V

437 D29018 Inj. Sodium Chloride I.P(NormalSaline) 3% W/V

438 D30001 Tab. Calcium & Vit. D3 (Film coated)

439 D30022 Calcium & Vit. D3 Suspension

440 D30025 Inj. Methylcobalamine

441 D30026 Tab. Pyridoxine I.P

442 D30010 Tab. Riboflavin I.P (coated)

443 D30002 Cap. Vit A I.P

444 D30009 Inj. Vit. A I.P

445 D30012 Vitamin A Solution (Concentrated) I.P

446 D30017 Vitamin A Solution (Concentrated)

447 D30007 Cap. Vit A.D (Therapeutic)

448 D30028 Inj. Vitamin B Complex

449 D30003 Cap. Vitamin B Complex

450 D30020 Syp. Vitamin B-Complex

451 D30006 Tab. Vitamin C I.P

452 D30016 Tab. Vitamin C (Chewable)

453 D30023 Vit. E Drop

454 D30029 Susp. Zinc Acetate

[57]

455 D30015 Tab. Zinc Acetate / Sulphate (Dispersible Tablets)

456 D34004 Absorbent Cotton I.P

457 D34002 Cotton Bandage IS 863

458 D34003 Cotton Cloth for Plaster of Paris Bandages, Variety - 1 IS : 4738

459 D34008 Roller Bandage IS 863

460 D34001 Handloom Cotton Gauze, Bleached IS 758 Absorbent,Non -Sterilised

461 D31018 Black Disinfectant Fluid (Phenyl) IS 1061

462 D31014 Bleaching Powder as per B.I.S.

463 D31040 Borax Glycerin

464 D31027 Gentian Violet

465 D31015 Tab. Halazone for Solution U.S.P

466 D31020 Tab. Sodium Dichloroisocyanurate

467 D31041 Soda Lime

468 D31001 Sterile Water For Injection I.P

469 D38001 RTI / STI Kit 1 Each Kit contains: Tab. Azithromycin (1 gm) IP – 1Tab. Tab. Cefixime 400mg) IP - Tab.

470 D38002 RTI / STI Kit 2 Each Kit contains : Tab.Secnidazole (1 gm) IP – 2Tab. Tab. Fluconazole 150mg) IP - Tab.

471 D38003

RTI / STI Kit 3 Each Kit contains: Inj. Benzathine Penicillin 2.4 MU IP-1 Vial and Tab. Azithromycin 1gm IP -1 Tab. And Sterilised Disposable syringe with 21G needle ( IS No. 12655) ( 1.5 inches) 10ml. – 1 No. and Sterile water for injection 10ml-1 No.

472 D38004 RTI / STI Kit 4 Each Kit contains : Cap / Tab. Doxycycline (100 mg.) IP-30 Tab./Cap. Tab. Azithromycin (1 gm.) IP – 1Tab.

473 D38005 RTI / STI Kit 5 Each Kit contains: tab. Cefixime 400mg – 21 Tab.

474 D38006

RTI / STI Kit 6 Each Kit contains: Tab. Cefixime (400 mg.) IP -1 Tab. And Tab. Metronidazole (400 mg.) IP -28 Tab. And Tab./cap. Doxycycline (100 mg.) IP -28 Cap./Tab.

475 D37007 RTI / STI Kit 7 Each Kit contains: Cap/ Tab. Doxycycline (100 mg.) IP-42 Tab./Cap. Tab.

[58]

Azithromycin (1 gm) IP – 1Tab.

476 D32024 ART Regimen (Dual Drug) Dispersible Each Disp. Tab. Contain Lamivudine 30 mg. + Nevirapine 50 mg. + Stavudine 6 mg.

477 D32025 ART Regimen (Dual Drug) Each Tab. Contains Lamivudine 40 mg. + Nevirapine 70 mg. + Stavudine 10 mg.

478 D32026 ART Regimen (Triple Drug) Each Disp. Tab. Contain Lamivudine 430 mg. + Stavudine 10 mg.

489 D32027 ART Regimen (Dual Drug) Each Tab. Contains Lamivudine 40 mg. + Stavudine 10 mg.

490 D38010

Anti-TB Kit 2 Each kit contains : INH, IP – 50. : 1 Tab. RMP, IP – 100 mg. : Tab. PZN, IP – 250 mg. : Tab.

491 D38010 Anti-TB Kit 2

492 D11016 Blister Combipack (Tab. Rifampicin 100mg + INH (Isonicotinylhydrazine) 50mg + Pyrazinamide 300 mg.) Dispersible Kid Tab.

493 D11017 Blister Combipack (Tab. Rifampicin 100 mg. + INH (Isonicotinylhydrazine) 50 mg.) Dispersible Kid Tab.

494 D11018

Anti-TB Schedule – 5 Rifampicin 750 mg. – 1 Tab. Isoniazid IP 75 mg. – 1 Tab. Ehambutol IP 200 mg. – 1 Tab. Pyrazinamide IP 250 mg. – 1 Tab.

495 D11019

Anti-TB Schedule – 6 Rifampicin 75 mg. – 3 Tab. Isoniazid IP 75 mg. – 3 Tab. Pyridoxine HCL IP 5 mg. – 4 Tab.

496 D11020

Anti-TB Schedule – 7 Rifampicin 150 mg. – 1 Tab. Isoniazid IP 150 mg. – 1 Tab. Ethambutol IP 400 mg. – 1 Tab. Pyrazinamide IP 500 mg. – 1 Tab.

497 D11021

Anti-TB Schedule – 8 Rifampicin 150 mg. – 3 Tab. Isoniazid IP 150 mg. – 3 Tab. Pyridoxine HCL IP 5 mg. – 4 Tab.

498 D11030

Anti-TB - Cat-I - Intensive Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 1 Tab. Ethambutol IP 800 mg. – 1 Tab.

[59]

Pyrazinamide IP 750 mg. – 1 Tab. Ehambutol IP 400 mg. – 1 Tab.

499 D11031 Anti-TB - Cat-I - Continuous Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab.

500 D11032

Anti-TB - Cat-II - Intensive Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab. Ethambutol IP 800 mg. – 2 Tab. Ethambutol IP 400 mg. – 2 Tab. Pyrazinamide IP 750 mg. – 2 Tab. Inj. Streptomycin Sulphate I.P – 0.75 mg. / Vial

501 D11033

Anti-TB - Cat-II - Continuous Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab. Ethambutol IP 800 mg. – 2 Tab. Ethambutol IP 400 mg. – 2 Tab.

502 D14027 Tab. Artemether 60 mg. + Lumefantrine 360 mg. (Dispersible Tablet)

503 D38011 Tab. Artemether40mg + Lumefantrine240mg

504 D38014 Tab. Artemether 60 mg. + Lumefantrine 360mg.

505 D38012 Tab. Artemether 80 mg. + Lumefantrine 480 mg.

506 D38015 Susp. Artemether + Lumefantrine

507 D38016 Syp. Artemether + Lumefantrine

508 D38013 Tab. Anti-Malarial Combipack Containing Artesunate Tablet, Sulphadoxine and Pyrimethamine Tab.

509 D02011 Lignocaine Spray (Topical)

510 D02012 Lignocaine Topical Solution (4%)

511 D02013 Lignocaine Viscous Topical Solution

512 D02014 Inj. Lignocaine + Adrenaline IP

513 D02015 Inj. Levobupivacaine

514 D02016 Inj. Levobupivacaine

515 D02017 Inj. Ropivacaine Hydrochloride

516 D04039 Inj. Butorphanol Tartrate

517 D04050 Inj. Diclofenac Sodium Aquous Preparation IP

518 D04051 Diclofenac Suppository

[60]

519 D04023 Tab. Etoricoxib (Coated) IP

520 D04053 Cap. Indomethacin

521 D04035 Inj. Ketorolac Ketoralac Tromethamine inj. IP

522 D04054 Tab. Lornoxicam

523 D04041 Inj. Nalbuphine Hydrochloride

524 D04055 Tab. Naproxen IP

525 D04056 Inj. Paracetamol I.V IP

526 D04057 Paracetamol Rectal Suppository

527

528 D04059 Tab. Serratiopeptidatase

529 D04060 Inj. Buprenorphine

530 D04061 Inj. Fentanyl Citrate

531 D39001 Tab. Leflunomide

532 D39002 Tab. Leflunomide

533 D08009 Tab. Ivermectin

534 D08010 Tab. Praziquintal

535 D08011 Inj. Sodium Stibo Gluconate

536 D05026 Inj. Hydrocortisone Sodium Succinate (with diluents in plastic container)

537 D05027 Tab. Hydrocortisone

538 D05028 Tab. Levocetirizine DiHCl + Monteleukast

539 D05016 Syp. Levocetirizine (Palatable, with measuring cap and plastic container as per I.P)

540 D05029 Inj. Methylprednisolone

541 D05030 Inj. Methylprednisolone

542 D05031 Tab. Methylprednisolone

543 D05032 Inj. Triamcinolone Acetonide

544 D23016 Tab. Carbimazole

545 D23017 Tab. Gliclazide

546 D23018 Tab. Glimepride

547 D23019 Pen Insulin

548 D23020 Pen Insulin (25% / 75%)

[61]

549 D23021 Pen Insulin (50% / 50%)

550 D23022 Inj. Insulin Glargine

551 D23023 Tab. Levo Thyroxine Sodium I.P

552 D23003 Inj. Mixed Gas Gangrene Antitoxin I.P

553 D23024 Tab. Propylthiouracil I.P

554 D23025 Tab. Vildagliptin

555 D07023 Inj. Citicolin

556 D07024 Tab. Citicolin

557 D07025 Syp. Levetiracetam

558 D07026 Tab. Levetiracetam

559 D09113 Tab./Cap. Amoxycillin & Clavulanic Acid

560 D09112 Inj. Amoxycillin + Clavunic Acid (with diluents in plastic container)

561 D09109 Amoxycillin Dry Syrup (Palatable, plastic container as per I.P with Dropper)

562 D09056 Inj. Ampicillin Sodium I.P

563 D09143 Inj. Azithromycin (with diluents in plastic container)

564 D09144 Inj. Aztreonam (with diluents in plastic container)

565 D09145 Inj. Aztreonam (with diluents in plastic container)

566 D09146 Inj. Cefipime + Tazobactam (with diluents in plastic container)

567 D09147 Tab. Cefixime & Clavulanic Acid

568 D09148 Inj. Cefoperazone + Sulbactam (with diluents in plastic container)

569 D09149 Tab. Cefuroxime Axetil I.P

570 D09154 Inj. Clarithromycin (with diluents in plastic container)

571 D09155 Inj. Doripenem Monohydrate (with diluents in plastic container)

572 D09156 Tab. Gemifloxacin I.P

573 D09157 Inj. Imipenem + Cilastatin Sodium I.P

574 D09158 Inj. Imipenem + Cilastatin Sodium (with diluents in plastic container)

575 D09159 Levofloxacin Infusion

576 D09161 Inj. Netlilmicin

[62]

577 D09162 Inj. Polymixin B Sulphate (with diluents in plastic container)

578 D09163 Roxythromycin Drop

579 D09164 Inj. Tigecycline

580 D13010 Inj. Ofloxacin + Ornidazole

581 D13011 Inj. Tinidazole IV

582 D40001 Inj. Gancyclovir

583 D40002 Cap. Oseltamivir I.P

584 D40003 Tab. Telbivudine

585 D40004 Tab. Tenofovir Disoproxil Fumarate I.P

586 D12021 Inj. Amphotericine B Liposomal I.P

587 D12022 Inj. Caspofungin

588 D12023 Tab. Voriconazole

589 D12024 Inj. Voriconazole

590 D20006 Tab. Acetazolamide I.P

591 D20007 Tab. Hydrochlorothiazide I.P

592 D20011 Tab. Metolazone

593 D20013 Inj. Torsemide

594 D20015 Tab. Torsemide

595 D17079 Inj. Papaverine HCl

596 D25030 Atropin Eye Drop

597 D25032 Chlorhexidine Oral Gel

598 D25033 Cyclopantolate Eye Drop I.P

599 D25034 Difluprednate + Moxifloxacin Eye Drop

600 D25035 Moxifloxacin Eye Drop I.P

601 D25036 Dorzolamide Eye Drops

602 D25037 Fluorescein-Stain Strip

603 D25039 Hypromellose Eye Drop

604 D25040 Inj. Hydroxypropyl Methylcellulose

605 D25041 Natamycin Eye Drop

606 D25042 Ofloxacin + Clotrimazole + Demamethasone Ear Drop

607 D25043 Ofloxacin + Demamethasone Eye / Ear Drop

[63]

608 D25008 Pilocarpine Eye Drops I.P

609 D25044 Proparacaine Eye Drop

610 D25045 Salmeterol Xlnafoate + Fluticasone Proprionate Inhaler I.P

611 D25046 Terpentine Oil + Chlorbutor + Paradichloro Benzene Ear Drop

612 D25047 Xylometazoline Hydrochloride Nasal Drop

613 D25048 Xylometazoline Hydrochloride Nasal Drop

614 D29019 Inj. Glycine

615 D29020 Inj. Invert Sugar I.V

616 D29021 Plasmaexpander Infusion Pentastarch

617 D29022 I.V Sodium Chloride (Normal Saline)

618 D29023 I.V Sodium Chloride (Normal Saline)

619 D29024 Tab. Tolvaptan

620 D05033 Tab. Mycophenolate Mofetil

621 D05034 Tab. Mycophenolate Mofetil

622 D05035 Tab. Mycophenolate Sod.

623 D05036 Tab. Mycophenolate Sod.

624 D05037 Tab. Tacrolimus

625 D05038 Tab. Tacrolimus

626 D05020 Cap. Thaliodamide

627 D33080 Inj. Bortezomib

628 D33049 Tab. Cyclophosphamide (coated)

629 D33081 Tab. Cyclophosphamide (coated)

630 D33082 Syp. Cyclosporine

631 D33067 Cap. Cyclosporine

632 D33083 Cap. Cyclosporine

633 D33084 Inj. Dacarbazine

634 D33085 Inj. Dacarbazine

635 D33086 Tab. Nilotinib

636 D33087 Tab. Nilotinib

[64]

637 D33088 Inj. Paclitaxel

638 D33089 Inj. Paclitaxel

639 D33090 Inj. Rituximab

640 D33091 Inj. Rituximab

641 D33092 Tab. Tamoxifen

642 D33093 Tab. Tamoxifen

643 D33094 Tab. Tamoxifen

644 D21033 Tab. Drotaverine HCl

645 D21039 Inj. Hyoscine Butylbromide

646 D21040 Inj. Levosulpiride

647 D21041 Inj. L-ornithine-L-aspartate

648 D21042 Inj. Octreotide

649 D21034 Inj. Palonosetron

650 D21043 Inj. Peginterferon Alfa-2a

651 D21044 Inj. Peginterferon Alfa-2a

652 D21045 Inj. Peginterferon Alfa-2b

653 D21046 Inj. Peginterferon Alfa-2b

654 D21047 Tab. Sulphasalazine

655 D41001 Tab. Alfuzosin

656 D41002 Tab. Derifenacin

657 D41003 Tab. Derifenacin

658 D41004 Cap. Dutasteride

659 D41005 Tab. Flavoxate

660 D41006 Cap./Tab. Tamsulosin

661 D26019 Inj. 17 Hydroxy Progesterone Capreote

662 D26020 Inj. 17 Hydroxy Progesterone Capreote

663 D26021 Tab. Estradiol

664 D26022 Tab. Estradiol

665 D26023 Inj. Human Chorionic Gonadotrophin

666 D26024 Inj. Human Menopausal Gonadotrophin

667 D26025 Inj. Human Menopausal Gonadotrophin

[65]

668 D26026 Tab. Medroxy Progesterone

669 D26027 Cap. Micronised Progesteron

670 D26018 Tab. Magnesium Sulphate

671 D18034 Framycetin Cream

672 D18035 Tab. Isotretinoin

673 D18036 Cap. Itraconazole

674 D18037 Ointment Neomycin

675 D18038 Povidone Iodine Mouth Wash

676 D18039 Povidone Iodine Solution

678 D18040 Cream Sertaconazole Nitrate

679 D18041 Sertaconazole Nitrate Vaginal Pessary

680 D18042 Tab. Finasteride

681 D18043 Tacrolimus Ointment

682 D18044 Tacrolimus Ointment

683 D42001 Tab. Baclofen

684 D42002 Tab. Clopidogrel + Aspirin

685 D42003 Inj. Interferon Beta 1a

686 D42004 Tab. Tetrabenazine

687 D17060 Tab. Carvidolol

689 D17061 Tab. Clonidine HCl

690 D17062 Inj. Enalapril

691 D17063 Tab. Enalapril Maleate

692 D17064 Tab. Ivabradine

693 D17065 Inj. Levosimendan

694 D17014 Tab. Lisinopril

695 D17066 Tab. Losartan Potassium

696 D17067 Tab. Olmesartan

697 D17068 Tab. Ranolazine

698 D17069 Inj. Reteplase

699 D17070 Tab. Rosuvastatin

700 D17071 Inj. Tenecteplase

[66]

701 D17072 Tab. Verapamil

702 D17073 Tab. Verapamil

703 D17074 Tab. Verapamil

704 D17075 Tab. Glyceriletrinitrate

705 D17076 Tab. Propranolol

706 D17077 Tab. Ranolazine

707 D17078 Tab. Trimetazidine

708 D16024 Tab. Deferasirox

709 D16025 Inj. Desferrioxamin

710 D16040 Tab. Eltrombopag

711 D16041 Inj. Erythropoitin

712 D16042 Inj. Erythropoitin

713 D16043 Inj. Erythropoitin

714 D16044 Inj. Ferric Carboxy Maltose

715 D16045 Inj. Methoxy Polythene Glycon Epoetinbta

716 D43001 7% Amino Acid for kidney

717 D43002 8% Amino Acid for liver

718 D43003 Inj. Amino Acid I.V

719 D43004 Inj. Amino Acid I.V

720 D43005 Inj. Dobutamine HCl

721 D43006 Inj. Dobutamine HCl

722 D43007 Inj. Fat Emulsion I.G

723 D43008 Inj. Fat Emulsion I.G

724 D43009 Inj. Fat Emulsion 10%

725 D43010 Inj. Fat Emulsion 20%

726 D43011 Inj. Isoprenalin HCl

727 D43012 Multivitamin Injection

728 D43013 Inj. Sodium Nitroprusside

729 D43014 Inj. Sodium Tetradecyl Sulfate

730 D44001 Inj. Human Albumin

731 D44003 Inj. Human Albumin IV

[67]

732 D44004 Syp. Lactulose

733 D44005 Inj. Octreotide

734 D44006 Tab. Rifaximin

735 D44009 Inj. Terlipressin Acetate

736 D44010 Tab. Ursodeoxycholic Acid

737 D44011 Tab. Ursodeoxycholic Acid

738 D45001 Barium Sulphate HD contrast

739 D45002 Barium Sulphate single contrast

740 D45009 Inj. Iopamidol

741 D45010 Inj. Iopamidol

742 D45011 Inj. Meglumine Diatrizoate

743 D45012 Inj. Meglumine Diatrizoate

744 D45013 Inj. Meglumine diatrizoate + Sodium Diatrizoate

745 D45014 Inj. Meglumine diatrizoate + Sodium Diatrizoate

746 D45016 Pedicloryl Oral Solution

747 D46001 Idoform

748 D46002 Benzoin

749 D46003 Storax

750 D46004 Sodium Hypochlorite Solution

751 D46005 Zinc Oxide

752 D46006 Eugenol

753 D46007 Solvent Ether

754 D30031 Tab. Vit. D3

755 D30032 Inj. Vit. D3

756 D30033 Vit. D3

757 D30034 Tab. Vit. D3

758 D30035 Tab. Calcium Citrate Maleate + Calcitrol + Vit. K27

759 D30036 Tab. Ferrous Sulphate + Folic Acid + Methylcobalamine

760 D30037 Tab. Folic Acid + Pyridoxine + Methylcobalamine

761 D31042 Budesonide Repsules

[68]

762 D31043 Inj. Calcium Chloride

763 D31044 Tab. Formaldehyde (Formalin)

764 D31045 Tab. Isoprenaline Sulfate

765 D31046 Tab. Nikorandril

766 S02113 Whole Blood Finger Prick Test Kit for HIV

767 S02130 Hydrogen Sulphide (H2S) strip test kit

768 S02109 Monovalent Rapid Diagnostic Test Kits

769 S02110 Bivalent Rapid Diagnostic Test Kit

770 S02131 Ortho-toluidine Kit (OT Kit)

771 S02053 RPR Test Kit for Syphilis

772 S01001 Black Braided SilkSize:- 1, ( Non Sterile) 25mt. / Reel (without needle) U.S.P, with CE certification

773 S01002 Black Braided SilkSize:- 1-0, ( Non Sterile) 25mt. / Reel (without needle) U.S.P, with CE certification

774 S01003 Black Braided SilkSize:- 1-0, length: 76cm, 1 / 2 Circle Round Bodied 30 mm needle (Sterilized) U.S.P, with CE certifi

775 S01004 Sterilised Surgical Suture Black Braided SilkSize:-1, length: 2 x 75cm, ( Precut and Pre Sterilized) U.S.P, with CE certification

776 S01005

Sterilised Surgical Suture Black Braided SilkSize:- 1-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

777 S01006

Sterilised Surgical Suture Monofilament Polyamide BlackSize:-1, length: 2 x 76cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

778 S01007

Sterilised Surgical Suture Monofilament Polyamide BlackSize:-1-0, length: 2 x 76cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

779 S01008 Catgut PlainSize:- 1-0, length: 1 x 152cm,U.S.P,with CE certification

780 S01009 Catgut PlainSize:-2-0, length: 1 x 152cm, U.S.P,with CE certification

781 S01010 Catgut ChromicSize:- 1, length: 1 x 152cm, (without needle) U.S.P, with CE certification

[69]

782 S01011 Catgut ChromicSize:-1-0, length: 1 x 152cm, (without needle) U.S.P, with CE certification

783 S01012

Catgut Chromic AtraumaticSize:- 1-0, length: 76cm, 1/ 2 Circle Round Bodied (45mm needle) U.S.P,with CE certification

784 S01013

Catgut Chromic AtraumaticSize:-1, length: 76cm, 1/ 2 Circle Round Bodied (40mm needle) (Heavy) U.S.P,with CE certification

785 S01014

Catgut Chromic AtraumaticSize:- 1-0, length: 76cm, 1/ 2 Circle Round Bodied (40mm needle) U.S.P,with CE certification

786 S01015

Catgut Chromic AtraumaticSize:-1-0, length: 76cm, 1/ 2 Circle Round Bodied (30mm needle) U.S.P,with CE certification

787 S01016

PolypropyleneSize:- 1, length: 70cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

788 S01017

PolypropyleneSize:- 1-0, length: 70/90cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

789 S01018

PolyglactinSize:-1, length: 90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

790 S01019

PolyglactinSize:- 1-0, length: 90cm, 1/2 Circle Round Bodied 40mm (needle) U.S.P,with CE certification

791 S01042

Poly Propylene MeshSize:- 15xSize:- 15cm, with CE certification

792 S01043

Absorbable Polyglactin Mesh + Poly PropyleneSize:- 15xSize:- 15cm, with CE certification

793 S01044

Absorbable Polyglactin Mesh + Poly PropyleneSize: 6 x 11cm, with CE certification

794 S01045

Sterilised Surgical Suture Black Braided SilkSize:-2, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

795 S01046

Sterilised Surgical Suture Black Braided SilkSize:- 3-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

796 S01047

Sterilised Surgical Suture Black Braided SilkSize:- 4-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

797 S01048

Sterilised Surgical Suture Monofilament Polyamide BlackSize:- 3-0, ( Precut & Pre Sterilized) U.S.P, with CE certification

798 S01049 Sterilised Surgical Suture Monofilament

[70]

Polyamide BlackSize:- 4-0, ( Precut & Pre Sterilized) U.S.P, with CE certification

799 S01050

PolypropyleneSize:- 2, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P, with CE certification

800 S01051

S01051 - PolypropyleneSize:- 3-0, length: 70/90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P, with CE certificatio

801 S01052

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 16mm (with needle) U.S.P, with CE certification

802 S01053

PolypropyleneSize:- 2-0, length: 70/90cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

803 S01056

PolypropyleneSize:-3-0, length: 70cm, 1/2 Circle Round Bodied 25-30mm (needle) U.S.P,with CE certification

804 S01057

-

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

805 S01058

-

PolyglactinSize:- 3-0, length: 90cm, 1/2 Circle Round Bodied 26-30mm (Needle) U.S.P,with CE certification

806 S01059

-

PolyglactinSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 16mm (Needle) U.S.P,with CE certification

807 S01062

-

PolyglactinSize:- 5-0, length: 45cm, 1/2 Circle Round Bodied 12mm (needle) U.S.P,with CE certification

808 S01068

-

Black Braided SilkSize:- 2-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certifi

809 S01069

-

Black Braided SilkSize:-3-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certific

810 S01070

-

Black Braided SilkSize:- 4-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certifi

811 S01071

-

Sterilised Surgical Suture Black Braided SilkSize:-2-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

812 S01072

-

Catgut Chromic AtraumaticSize:-2-0, length: 76cm, 1/ 2 Circle Round Bodied (45mm needle) U.S.P,with CE certification

813 S01073 -

Catgut Chromic AtraumaticSize:- 3-0, length: 76cm, 1/ 2 Circle Round Bodied (20mm

[71]

needle) U.S.P,with CE certification

814 S01074

-

Catgut Chromic AtraumaticSize:- 4-0, 1/ 2 Circle Round Bodied (45mm needle) U.S.P, with CE certification

815 S01075

-

PolypropyleneSize:- 2-0, length: 70cm, 1/2 Circle Round Bodied 20-30mm, with needle U.S.P, with CE certification

816 S01076

-

PolypropyleneSize:- 3-0, length: 70cm, 1/2 Circle Round Bodied 20mm, with needle U.S.P,with CE certification

817 S01077

-

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 20mm (with needle) U.S.P, with CE certification

818 S01078

-

PolyglactinSize:- 2, length: 90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

819 S01079

-

PolyglactinSize:- 2-0, length: 90cm, 1/2 Circle Round Bodied 26-30mm (needle) U.S.P,with CE certification

820 S01080

-

PolyglactinSize:- 3-0, length: 70cm, 1/2 Circle Round Bodied 20mm (Needle) U.S.P,with CE certification

821 S01081

-

PolyglactinSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 20mm (Needle) U.S.P,with CE certification

822 S01082

-

PolyglactinSize:- 5-0, length: 45cm, 1/2 Circle Round Bodied 16-20mm (needle) U.S.P,with CE certification

823 S01083

-

Monofilament Polyamide Black Breaded SilkSize:- 2-0, 3/8 Circle Bodied 45mm needle, reverse cutting

824

S02001

Disposable Syringes With colour coded (as per BIS) needle Sterilised, Luer Mount, Non - toxic 2 CC, 5 CC, 10 CC, 20 CC, 50 CC as per IS :10258

825 S02003

Disposable sterilised Needles in blister pack20 G - 24 G, IS No: 10654: 2002, ISO: 7864.1993 with CE certificate

826 S02004

-

Disposable Tuberculin / B.C.G Syringes1CC / ml, With Needle Sterilised Non-Sterilised Toxic 1CC / ml. As per Drugs & Cosmetic Act 1940, w

827 S02005

-

Disposable Insulin Syringes40 Unit, With Needle, Sterilised Non -Toxic, Unit 40 with CE certification

[72]

828 S02006

-

Disposable Insulin Syringes100 Unit, With Needle, Sterilised Non-Toxic, Unit 100 with CE certification

829 S02007 -

Disposable Sterilised Tuberculin / Insulin NeedleIn Blister Pack with CE certification

830 S02008

-

Intra CathAdult, (two way) with closing Cover Type II Sterilised Size 18, 20,22 (Adult) with CE certification

831 S02009

-

Intra CathChild, (two way) with closing Cover Type II Sterilised Size 24 (Child) with CE certification

832 S02011

Intravenous SetAdult, With built in Airway moulded chamber and Needle, Sterile, Disposable, Non - Toxic, Non Pyroge

833 S02012

-

Intravenous SetChild, With built in Airway moulded chamber and Needle, Sterile, Disposable, Non - Toxic, Non Pyroge

834 S02013

Blood Administration SetDisposable Sterilised by ETO as per Drugs and Cosmetics Act-1940, I.S. No. 9824 (part 3 of 1996) wit

835 S02014

Surgical NeedlesSuture Needles, Straight Cutting Needle different sizes 6 to 10

836 S02015

Surgical NeedlesSuture Needles, Curved Cutting Needle different sizes 6 to 10

837 S02016

Surgical NeedlesSuture Needles, Curved Round Bodied different sizes 6 to 10

838 S02018

Surgicals BladesPre - sterile with Gamma radiation for handle no. 4 sizes 10 , 12 ,15,20,22, 24, ISI : 3319:1995 wit

839 S02024

Foleys Urinary CatheterSize: 16 & 18, Silkolatex (Pre - sterile) 2 way sterile, Non - toxic with CE certification

840 S02025

Foleys Urinary CatheterSize: 16, 18 AND 20, Silkolatex (Pre - sterile) 3 way sterile, Non - toxic with CE certification

841 S02026

Urinary Drainage BagSterilised with non return valve and Drainage outlet with a capacity of 2000ml , with marking non to

842 S02031

Ryle’s TubePolythene ( P.V.C) Pre -sterile (Length 105ms) Sterile Non toxic , Pyrogen free , with Radio Opaque

843

S02034

Operation Gloves (Sterilised)BIS specifications gloves, surgical rubber made ofHypoallergic latex.-100% electronically tested, ste

844 S02037 Sterile Disposable Blood Lancet (Pricking

[73]

Needle).

845

S02045

Auto disable syringes sterilised2 CC, (as per WHO, UNICEF specification), 2CC, 21G-25G needle with CE certification IS : 10258 (Part – 3)

846

S02046

Auto disable syringes sterilised5 CC, (as per WHO, UNICEF specification), 5CC, 21G-25G needle with CE certification IS : 10258 (Part – 3)

847

S02049

Disposable Examination Gloves6", 61/2", 7", 71/2",Sterilised, small, medium and large,pre-powdered, with CE certified,surgical rubb

848 S02051

Umbilical cord clamp / Vascular clamp (sterilised).

849 S02053

VDRL Rapid Test Kit, (RPR) Rapid Plasma Regime.AS PER TENDER SPECIFICATION

850 S02078 N 95 facemasks As per Tender Specification

851 S02092

Spinal Needle Disposable Adult as per BIS23 / 25G (70 - 90mm) with hub (Colour coaded as per ISO Standard

852 S02094

Disposable Syringes 20 CC, with colour coded (as per BIS) needle Sterilised, Luer Mount, Non - toxic CGS 10CC as per Dr

853 S02095

Naso-Gastric Tube (Infant feeding tube)Size 5, 6

854 S02096

Suction catheter (Plain)Size 6 Fr and 8 Fr with colour code Length: Neonatal - 30cm, Paediatric - 40cm and Adult - 50cm. IS

855 S02097

Endotracheal TubeSize 2.5, 3, 3.5, 4 ISO Certified Product

856

S02101

Three Way StopcockThree Caps. (Blue, Green and Red Colour), Sterile, non-pyrogenic. ISO Certified Product. S02107 - Epidural SetEpidurarl Syringe - 1,Epidural Needle - 18G - 1,Epidural Catheter

857 S02109

Monovalent Rapid Diagnostic Test KitsAs per tender specification

858 S02110

Bivalent Rapid Diagnostic Test KitAs per tender specification

859 S02111

NS1 Elisa Kit For Dengue TestAs per tender specification

860 S02118

Disposable Delivery Kit (ETO Sterilised)AS PER TENDER SPECIFICATION

861 S02119 PAP Smear KitCusco Vaginal Speculum - 1

[74]

piece, Endocervical Brush - 1 piece, Wooden Ayers Spatula - 1 piece, Glas

862 Mosquito Larvicide Oil (MLO)

863 Temephos (50%) EC

864 Deltamethrin Flow 2.5 %

865 Pyrethrum Extract (2%)

866 Diflubenzuron 25% WP

867 Bivalent Rapid Diagnostic Test Kit for Maleria

868 NS1 Elisa Kit for Dengue Test

869

Anastrazole tab I.P.

870

Aprepetant Tab.

871

Arsenic trioxide I.P

872

Bendamustine Inj.

873

Bevacizumab Inj.

874

Bicalutamide Tab. I.P

875

Bortezomib Inj.

876

Cabazitaxel Inj.

878

Capecitabine Tab. I.P

879

Carboplatin Inj. I.P

880

Cetuximab Inj.

881

Chlorambucil Tab. I.P

882

Cladribine Inj.

883

Cytarabine Inj.

884

Dacarbazine Inj.

885

Dactinomycin Inj.

886

Daunorubicin Inj. I.P

887

Decitabine Inj.

888

Desfeprioxamine Inj. I.P

889

Docetaxel Inj. I.P

890

Docetaxel lyophilized Inj.

891

Doxorubicin rtu inj

892

Doxorubicin liposomal Inj.

[75]

893

Epirubicin Inj

894

Erlotinib Tab. I.P

895

Estramustine Tab.

896

Everolimus Cap.

897

Exemestane TaB.

898

Filgrastim pfs Inj.

899

Figrastim Inj. I.P

900

Filgrastim peg Inj.

901

Fludarabine Tab.

902

Fludarabine Inj. I.P

903

Fulvestrant Inj.

904

Gefitinib Tab.

905

Ibandronic acid Inj.

906

Idarubicin Inj.

907

Ifosfamde with mesna Inj.

908

Lenalidomide Cap.

909

Letrozole Tab.

910

Leucovorin calcium Inj. I.P

911

Leuprolide acetate Inj.

912

Lomustine Cap.

913

Megestrol Tab. I.P

914

Melphalan Tab. I.P

915

Mercaptopurine (6-mp) Tab. I.P

916

Mesna inj.

917

Mitomycin-c inj.

918

Mitoxantrone Inj.

919

Nilotinib Cap.

920

Mimotuzumab Inj.

921

OxaliplatinInj.

922

Oxaliplatin rtu Inj.

923

Paclitaxel nanoparticle Inj.

[76]

924

Pazopanib Tab.

925

Pemetrexed inj.

926

Procarbazine Cap.

927

Rasburicase Inj.

928

Rituximab Inj.

929

Sargramostim Inj.

930

Sorafenib Tab.

931

Sunitinib Cap.

932

Tamoxifen Tab.

933

Temozolamide Cap.

934

Temsirolimus Inj.

935

Thalidomide Cap.

936

Zoledronic acid Inj.

937

Trabectedin Inj.

938

Trastuzumab Inj.

939

Tretinoin Cap.

940

Vinorelbine Inj.

941 D27027 Amisulpride

942 D27028 Amitriptyline + Chloridezepoxide

943 Carbamazepine CR

945 D27071 Chlorodiazepoxide

946 D27032 Dothiepin Tab.

947 D27043 Lithiumcarbonate Tab. I.P

948 D05021 Tab. levocetrizine

949 D27043 Nitrazepam Tab.

950 D09017 Norfloxacin

951 D27052 Procyclidine Tab. I.P

952 D27054 Quetiapine Fumarate Tab. I.P

953 D27061 Trifluperazine + Trihexyphenidyl Tab.

954 D27010 Thioridazine

956 D27020 Inj Haloperidol-LA

[77]

957 D07010 Inj Lorazepam

958 D21005 Inj Promethzine HCL

959 D03001 Inj Atropin Sulphate

960 D14018 Inj Artasunate

961 D09078 Inj Cefoporazone + Salbactum

962 D13003 Inj Metronidazol IV

963 D17013 Inj Dopamine HCL

964 D05001 Inj.Dexamethasone Sodium phosphata

965 D21030 Inj.Pantoprazole

967 D30003 Cap Vitmin B. complex

968 Rectified Spirit I.P

969 ECG Jelly

970 Micropore

971 Inj Fluanxol Decanoate

972 Inj Zuclopenthixol Decanoate

973 Sodium Fluoride (18F) Inj. I.P

974 EDTA powder

[78]

ANNEXURE – X

PRICE BID

Sl. No.

Drug Code

Name of Medicine / items / Drug

Rate excluding

tax

Tax applicable

in %

Total including

taxes

Extra charges for emergency testing as % of normal rate

1 D01019 Inj. Etomidate

2 D01005 Halothane

3 D01020 Isoflurane

4 D01021 Isoflurane

5 D01001 Inj. Ketamine HCl I.P

6 D01022 Inj. Propofol I.P (1%)

7 D01023 Sevoflurane USP

8 D01024 Sevoflurane

9 D01002 Inj. Thiopentone Sodium I.P

10 D02006 Inj. Bupivacaine I.P

11 D02008 Inj. Bupivacaine (Heavy)

12 D02009 Inj. Levobupivacaine

13 D02007 Lidocaine Hydrochloride gel 2% I.P.

14 D02001 Inj. Lignocaine HCl I.P.

15 D02003 Inj. Lignocaine HCl and Adrenaline Bitartrate I.P.

16 D02005 Inj. Lignocaine HCl and Dextrose I.P. (Heavy)

17 D02010 Inj. Ropivacaine Hydrochloride U.S.P

18 D03005 Inj. Dexmedetomidine

[79]

19 D03002 Inj. Glycopyrrolate

20 D01007 Inj. Midazolam I.P.

21 D01008 Inj. Atracurium Besylate I.P.

22 D17047 Inj. Ephedrine HCl I.P.

23 D24006 Inj. Neostigmine Methylsulphate I.P.

24 D24008 Inj. Neostigmine Methylsulphate +Glycopyrrolate

25 D24009 Tab. Pyridostigmine I.P.

26 D24010 Inj. Rocuronium Bromide

27 D24011 Inj. Succinyl Choline Chloride I.P.

28 D24005 Inj. Vecuronium Bromide

29 D04025 Tab. Aceclofenac I.P.

30 D04009 Tab. Diclofenac Sodium I.P (Coated)

31

D04010 Inj. Diclofenac SodiumAquous Preparation I.P

32 D04005 Tab. Ibuprofen I.P (Coated)

33 D04032 Susp. Ibuprofen

34 D04044 Tab. Mephenamic Acid (Disp. Tab.)

35 D04003 Syp. Paracetamol I.P

36 D04026 Paracetamol Drop

37 D04033 Inj. Paracetamol I.V

38 D04022 Tab. Paracetamol Kid (Disp. Tab.)

39 D04043 Tab. Paracetamol Kid (Scored Disp. Tab.)

[80]

40 D04002 Tab. Paracetamol I.P

41 D04045 Paracetamol Rectal Suppository

42 D04028 Tab. Codeine Phosphate I.P

43 D04046 Inj. Fentanyl Citrate I.P

44 D04011 Inj. Morphine Sulphate I.P

45 D04047 Tab. Morphine Sulphate I.P

46 D04008 Inj. Pentazocine Lactate I.P

47 D04029 Inj. Pethidine Hydrochloride I.P

48 D04021 Inj. Tramadol HCl

49 D04048 Tab. Tramadol Hydrochloride (Coated)

50 D33068 Tab. Azathioprine I.P

51 D33069 Tab. Hydroxy Chloroquine I.P

52 D33009 Tab. Methotrexate I.P (coated)

53 D05017 Inj. Betamethasone Sod. PhosphateI.P

54 D05011 Syp. Cetirizine Dihydrochloride I.P

55 D05010 Tab. Cetirizine Dihydrochloride I.P

56 D05006 Tab. Chlorpheniramine Maleate I.P

57 D05001 Inj. Dexamethasone Sodium Phosphate I.P

58 D05019 Tab. Dexamethasone I.P

59 D05022 Tab. Dexamethasone I.P

60 D05002 Inj. Hydrocortisone Sodium Succinate I.P

61 D05021 Tab. Levocetirizine Dihydrochloride I.P

[81]

62 D05023 Inj. Methylprednisolone I.P

63 D05024 Tab. Methylprednisolone I.P

64 D05025 Inj. Noradrenaline I.P

65 D05007 Inj. Pheniramine Maleate I.P

66 D05015 Tab. Prednisolone I.P

67 D33022 Syp. Prednisolone

68 D06004 Inj. Acetylcysteine

69 D06005 Tab. Activated Charcoal

70 D06006 Inj. Atropine I.V

71 D03001 Inj. Atropine Sulphate I.P

72 D06001 Inj. Dimercaprol I.P

73 D06007 Inj. Methylene Blue

74 D03003 Inj. Naloxone HCl I.P

75 D03004 Potassium Permanganate I.P

76 D06002 Inj. Pralidoxime Chloride / Iodide I.P

78 D06008 Inj. Sodium Nitrite

79 D06009 Inj. Sodium Thiosulfate I.P

80 D07003 Tab. Carbamazepine I.P(Controlled Release)

81 D07015 Tab. Carbamazepine I.P (Controlled Release)

82 D07016 Tab. Clobazam Capsule I.P

83 D07013 Inj. Fosphenytoin Sodium

84 D07010 Inj. Lorazepam I.P

[82]

85 D07017 Tab. Pramipexole

86 D07002 Inj. Phenobarbitone I.P

87 D07011 Phenobarbitone Oral Solution

88 D07001 Tab. Phenobarbitone I.P

89 D07007 Inj. Phenytoin Sodium I.P

90 D07018 Tab. Phenytoin Sodium I.P

91 D07019 Inj. Levetiracetam

92 D07020 Tab. Levetiracetam

93 D07012 Elixir Sodium Valproate I.P

94 D07021 Inj. Sodium Valproate I.P

95 D07022 Tab. Sodium Valproate (Controlled Release) (Enteric Coated)

96 D07005 Tab. Sodium Valproate (Controlled Release) (Enteric coated) I.P

97 D27093 Tab. Levodopa + Carbidopa I.P

98 D27060 Tab. Trihexyphenidyl I.P

99 D08004 Tab. Albendazole I.P(Chewable)

100 D08003 Susp. Albendazole I.P

101 D08008 Tab. Ivermectin

102 D08001 Tab. Mebendazole I.P

103 D09019 Inj. Amikacin Sulphate

104 D09101 Inj. Amoxycillin Trihydrate I.P

105 D09111 Tab. Amoxycillin Trihydrate I.P (Dispersible Tablet)

[83]

106 D09050 Cap. Amoxycillin Trihydrate I.P

107 D09060 Amoxycillin oral suspension I.P

108 D09004 Inj. Ampicillin Sodium I.P

109 D09089 Susp. Azithromycin

110 D09095 Azithromycin Oral Suspension

111 D09077 Tab. Azithromycin

112 D09006 Inj. Benzathine Penicillin I.P

113 D09051 Tab. CefadroxilI.P (Dispersible Tablet)

114 D09104 Cefadroxil Drop

115 D09026 Tab. Cefadroxil I.P

116 D09129 Inj. Cefepime I.P

117 D09096 Tab. Cefixime I.P Dispersible

118 D09091 Tab. Cefixime I.P

119 D09131 Inj. Cefoperazone & Sulbactam

120 D09132 Inj. Cefoperazone I.P

121 D09053 Inj. Cefotaxime Sodium I.P

122 D09119 Inj. Ceftazidime I.P

123 D09093 Inj. Ceftriaxone I.P

124 D09061 Inj. Chloramphenicol

125 D09020 Tab. Ciprofloxacin HCl I.P

126 D09007 Inj. Ciprofloxacin I.V. I.P

127 D09133 Tab. Clarithromycin I.P

[84]

128 D09003 Susp. Cotrimoxazole I.P

129 D09065 Tab. Cotrimoxazole Kid (Disp. Tab.)

130 D09110 Tab. Cotrimoxazole Paediatric I.P

131 D09002 Tab. Cotrimoxazole I.P

132 D09015 Cap. Doxycycline HCl I.P

133 D09016 Tab. Erythromycin Stearate I.P

134 D09010 Inj. Gentamicin Sulphate I.P

135 D09121 Inj. Linezolid I.V I.P

136 D09122 Tab. Linezolid I.P

137 D09135 Susp. Linezolid

138 D09124 Tab. Levofloxacin I.P

139 D09136 Inj. Meropenem I.P

140 D09137 Tab. Moxifloxacin

141 D09100 Tab. Nitrofurantoin I.P

142 D09017 Tab. Norfloxacin I.P

143 D09066 Tab. Norfloxacin (DispersibleTablet)

144 D09138 Susp. Ofloxacin I.P

145 D09033 Tab. Ofloxacin (DispersibleTablet)

146 D09073 Inj. Ofloxacin I.V I.P

147 D09139 Tab. Ofloxacin I.P

148 D09140 Tab. Penicillin G Potassium

149 D09087 Inj. Piperacillin + Tazobactam

[85]

150 D09141 Inj. Teicoplanin

151 D09070 Cap. Tetracycline I.P

152 D09120 Inj. Tobramycin I.P

153 D09106 Inj. Vancomycin I.P

154 D10002 Cap. Clofazimine I.P

155 D10001 Tab. Dapsone I.P

156 D11022 Inj. Capreomycin I.P

157 D11023 Cap. Cycloserine I.P

158 D11007 Tab. Ethambutol (coated)

159 D11024 Tab. Ethionamide I.P

160 D11004 Tab. INH I.P (Coated)

161 D11025 Inj. Kanamycin I.P

162 D11010 Tab. Pyrazinamide I.P (Coated)

163 D11009 Susp. Rifampicin I.P

164 D11002 Tab./Cap. Rifampicin I.P

165 D11027 Sodium PAS I.P

166 D11001 Inj. Streptomycin Sulphate I.P

167 D11029 Tab. Thiacetazone

168 D12018 Inj. Amphotericine B I.P

169 D12012 Clotrimazole Lotion

170 D12009 Clotrimazole Vaginal Pessaries I.P

171 D12007 Tab. Fluconazole (Dispersible Tab.)

[86]

172 D12019 Fluconazole Infusion

173 D12008 Tab. Fluconazole

174 D12020 Cream Terbinafine

175 D13005 Tab. Metronidazole I.P (Coated)

176 D13007 Susp. Metronidazole I.P (Oral Susp.)

177 D13003 Inj. Metronidazole I.V I.P

178 D13008 Tab. Ornidazole I.P (Coated)

179 D13011 Ornidazole Infusion I.P

180 D13002 Susp. Tinidazole (Oral Susp.)

181 D14018 Inj. Artesunate

182 D14001 Tab. Chloroquin Phosphate I.P (Coated)

183 D14002 Syp. Chloroquin Phosphate I.P

184 D14034 Tab. Primaquin Phosphate I.P (coated)

185 D14005 Inj. Quinine Di-Hydrochloride I.P

186 D14004 Tab. Quinine Sulphate I.P (coated)

187 D14010 Susp. Quinine Sulphate I.P

188 D09043 Syp. Diethylcarbamazine Citrate I.P

189 D09092 Tab. Diethylcarbamazine Citrate I.P (Coated)

190 D32007 Tab. Efavirenz I.P

191 D32006 Cap. Indinavir I.P

192 D32021 Lamivudine Oral Solution I.P

193 D32002 Tab. Lamivudine I.P

[87]

194 D32022 Nevirapine Oral Suspension I.P

195 D32003 Tab. Nevirapine I.P

196 D32023 Stavudine Oral Solution I.P

197 D32005 Cap. Stavudine I.P

198 D32020 Zidovudine Oral Solution I.P

199 D32001 Tab. Zidovudine I.P

200 D18016 Tab. Acyclovir

201 D18028 Inj. Acyclovir

202 D18029 Tab. Entecavir

203 D33057 Inj. 5 Fluorouracil I.P

204 D33063 Tab. 6 - Mercaptopurine I.P

205 D33062 Inj. Actinomycin D

206 D33048 Tab. Allopurinol I.P

207 D33065 Inj. Arabinocide

208 D33069 Inj. Bleomycin I.P

209 D33045 Tab. Busulfan I.P (coated)

210 D33055 Inj. Carboplatin I.P

211 D33024 Inj. Cisplatin I.P

212 D33002 Inj. Cyclophosphamide

213 D33064 Inj. Daunorubicin I.P

214 D33015 Inj. Doxorubicin HCl I.P

215 D33061 Inj. Epirubicin I.P

[88]

216 D33035 Tab./Cap. Etoposide I.P

117 D33071 Inj. Etoposide I.P

218 D33012 Inj. Fluorouracil I.P

219 D33072 Inj. Gemciatabine I.P

220 D33074 Inj. Ifosfamide

221 D33075 Tab. Imatinib I.P

222 D33053 Inj. L-Asperginase

223 D33011 Inj. Methotrexate I.P

224 D33079 Inj. Paclitaxel I.P

225 D33032 Inj. Vinblastine I.P

226 D33017 Inj. Vincristine Sulphate I.P

227 D16026 Inj. Antithymocyte Globuline(Equine)

228 D16023 Tab. Deferasirox

229 D16017 Tab. Doxylamine Succinate + Pyridoxine

230 D16036 Inj. Enoxaparin I.P

231 D16007 Inj. Ethamsylate

232 D16028 Tab. Ethamsylate

233 D16034 Inj. Human coagulation Factor IX I.P

234 D16032 Inj. Human coagulation Factor VIII I.P

235 D16037 Tab. Ferrous Sulphate + Folic Acid

236 D16031

Syp. Ferrous Sulphate + Folic Acid(Palatable with dropper and plastic container as per I.P, Auto- dispensing bottle)

[89]

237 D16011 Syp. Ferrous Sulphate + Folic Acid I.P

238 D16002 Tab. Folic Acid I.P

239 D16004 Inj. Heparin Sodium I.P

240 D16014 Inj. Hydroxocobalamine I.P

241 D16015 Cap. Hydroxyurea

242 D16016 Tab./Cap. Hydroxyurea

243 D16020 Tab. Iron (Sugar Coated)

244 D16019 Iron drop(Palatable, with dropper and plastic container as per I.P)

245 D16018 Inj. Iron Sucrose

246 D16021 Syp. Iron

247 D30021 Inj. Kenandione (Vit. K)

248 D30030 Tab. Kenandione (Vit. K)

249 D16005 Inj. Menadione (Vit-K3)

250 D16027 Solution Disodium Hydrogen Citrate

251 D16012 Inj. Tranexamic Acid I.P

252 D16013 Tab. Tranexamic Acid I.P

253 D16039 Inj. Vassopressin I.P

254 D20002 Inj. Frusemide I.P

255 D20001 Tab. Frusemide I.P

256 D17026 Tab. Hydrochlorothiazide I.P

257 D20004 Inj. Mannitol I.V I.P

258 D20005 Tab. Spironolactone I.P

[90]

259 D17048 Tab. Clopidogrel I.P

260 D17018 Inj. Glyceryl Trinitrate I.P

261 D17001 Tab. Isosorbide Dinitrate I.P

262 D17015 Tab. Amlodipine Besylate I.P

263 D17006 Tab. Atenolol I.P

264 D17049 Tab. Enalapril Maleate I.P

265 D17050 Inj. Esmolol Hydrochloride

266 D17030 Inj. Hydralazine I.P

267 D17033 Tab. Hydralazine

268 D17043 Inj. Labetalol I.P

269 D17042 Tab. Labetalol I.P

270 D17051 Tab. Losartan Potassium I.P

271 D17020 Tab. Methyl Dopa I.P (coated)

272 D17007 Tab. Metoprolol Tartarate ER

273 D17037 Tab. Metoprolol Tartarate I.P

274 D17016 Cap. Nifedipine I.P (Soft gelatin capsule)

275 D17052 Tab. Nifedipine Sustained Release I.P (SR)

276 D17053 Tab. Ramipril I.P

278 D17032 Tab. Telmisartan

279 D17054 Inj. Adenosine I.P

280 D17038 Tab. Amiodarone B.P

281 D17055 Tab. Carvedilol I.P

[91]

282 D17027 Tab. Digoxin I.P

283 D17034 Syp. Digoxin

284 D17040 Inj. Dobutamine HCl

285 D17013 Inj. Dopamine HCl (Intravienous infusion I.P )

286 D17029 Inj. Mephenteramine Sulphate I.P

287 D17041 Inj. Potassium Chloride I.P

288 D17056 Inj. Verapamil I.P

289 D17057 Tab. Verapamil IP

290 D17024 Tab. Aspirin I.P (Coated)

291 D17058 Tab. Aspirin I.P (Enteric Coated)

292 D17025 Inj. Streptokinase I.P

293 D17080 Tab. Atorvastatin I.P

294 D17082 Tab. Fenofibrate

295 D18028 Clindamycin Cream

296 D18029 Clobetasol Dipropionate Ointment I.P

297 D18021 Clotrimazole Mouth Paint

298 D18030 Cream Clotrimazole I.P

299 D18031 Cream Fluocinolone Acetonide I.P

300 D18003 Cream Silver Sulphadiazine I.P

301 D18002 Gamma Benzene Hexa Chloride + Cetrimide

302 D18019 Lotion Fluocinolone Acetonide

303 D18011 Lotion Permethrin

[92]

304 D18032 Mupirocin Ointment I.P

305 D18033 Oint Betamethasone Valerate

306 D18007 Povidone Iodine Solution I.P

307 D19008 Chloroxylenol Solution I.P

308 D19005 Lysol Solution I.P (Cresol With Soap)

309 D19013 Oint Nitrofurazone (Polyglycol Base)

310 D18024 Povidone Iodine Oint.

311 D19004 Soln. Cetrimide

312 D19009 Soln. Chlorohexidine Gluconate + Cetrimide + Isopropyl Alcohol I.P

313 D19007 Soln. Formaldehyde

314 D19006 Surgical Spirit I.P

315 D21003

Tab. Antacid (Dried Aluminium` Hydroxide gel I.P 250 mg. + Magnesium Hydroxide I.P 250 mg. + Methyl Polysiloxane 50 mg.)

316 D21035

Susp. / Gel Antacid Magaldrate 400 mg. + Simethicone 20 mg.) / 5 ml.

317 D21028 Dicyclomine Drop

318 D21013 Inj. Dicyclomine HCl I.P

319 D21011 Tab. Dicyclomine HCl I.P

320 D21014 Syp. Dicyclomine

321 D21010 Tab. Domperidone I.P

322 D21020 Susp. Domperidone I.P

[93]

323 D21036 Inj. Drotaverine

324 D21032 Tab. Drotaverine HCl I.P

325 D21031 Tab. Levosulpiride

326 D21004 Inj. Metoclopramide I.P

327 D21009 Cap./Tab. Omeprazole I.P

328 D21039 Inj. Ondansetron I.P

329 D21024 Tab. Ondansetron I.P (Dispersible Tablet)

330 D21038 Syp. Ondansetron I.P

331 D21012 Oral Rehydration salt I.P

332 D21018 Tab. Pantoprazole I.P

333 D21030 Inj. Pantoprazole

334 D21006 Syp. Promethazine I.P

335 D21005 Inj. Promethazine HCl I.P

336 D21037 Tab. Promethazine I.P

337 D21026 Tab. Rabeprazole I.P (Entric coated)

338 D21025 Inj. Rabeprazole (I.V)

339 D21002 Tab. Ranitidine I.P (coated)

340 D21001 Inj. Ranitidine HCl I.P

341 D21021 Susp. Sucralfate

342 D22013 Tab. Gliclazide

343 D22014 Tab. Glimepiride I.P

344 D22004 Tab. Glipizide I.P

[94]

345 D22012 Inj. Human Premixed Insulin(30/70)

346 D22009 Inj. Human Premixed Insulin(50/50)

347 D22002 Inj. Human Soluble Insulin I.P

348 D22010 Tab. Levo Thyroxin Sodium

349 D22003 Tab. Metformin HCl IP (coated)

350 D22016 Tab. Voglibose I.P

351 D23009 Inj. Rabies Vaccine, Human I.P

352 D23012 Inj. Tetanus Immunoglobulin I.P

353 D23010 Inj. Equine Rabies Immunoglobulin I.P

354 D23015 Inj. Hepatitis B Immunoglobulin I.P (HBIG)

355 D23011 Inj. Human Anti-D Immunoglobuline

356 D23014 Inj. Human Rabies Immunoglobuline

357 D23008 Inj. Snake Venom Antiserum I.P (Polyvalent) liquid form

358 D23002 Inj. Snake Venom Antiserum I.P (Polyvalent) lyophilized power form

359 D23005 Inj. Tetanus Vaccine (adsorbed) I.P.

360 D25029 Bimatoprost Eye Drop

361 D25011 Chloromycetin Eye Ointment (Applicap/Soft Capsule)

362 D25012 Ciprofloxacin Eye /Ear Drop I.P

363 D25022 Clotrimazole & Lignocaine Ear Drop

364 D25021 Fluorescein Sodium Eye Drop I.P

365 D25001 Gentamicin Sulphate Eye /Ear Drop I.P

[95]

366 D25025 Homatropine Eye Drop I.P

367 D25026 Lidocaine + Ofloxacin Ear Drop

368 D25023 Ofloxacin Ophthalmic Solution I.P

369 D25027 Phenylepherine Eye Drop

370 D29015 Saline Nasal Drop

371 D25028 Timolol Eye Drop I.P

372 D25024 Tropicamide +

Phenylephrine Eye Drop

373 D26005 Inj. Carboprost Tromethamine I.P

374 D26014 Dinoprostone Gel

375 D26013 Inj. Ethacridine Lactate

376 D26009 Inj. Hydroxy Progestrone I.P

377 D26011 Inj. Isoxsuprine HCl I.P

378 D26015 Tab. Isoxsuprine SR I.P

379 D26004 Tab. Isoxsuprine I.P

380 D26006 Inj. Magnesium Sulphate I.P

381 D26001 Inj. Methylergometrine Maleate I.P

382 D26003 Tab. Methylergometrine Maleate I.P

383 D26016 Inj. Micronised Progesteron

384 D26017 Cap. Micronised Progesteron

385 D26012 Tab. Mifepristone I.P

386 D26007 Tab. Misoprostol I.P

387 D26008 Tab. Norethisterone Acetate I.P

[96]

388 D26002 Inj. Oxytocin I.P

389 D27028 Tab. Amitriptyline + Chlordiazepoxide

390 D27030 Tab. Chlorpromazine + Thrihexyphenidyl

391 D27014 Tab. Clonazepam I.P

392 D27031 Tab. Clozapine I.P

393 D07006 Inj. Diazepam I.P

394 D27001 Tab. Diazepam I.P

395 D27076 Tab. Disulfiram I.P

396 D27034 Tab. Divalproex Sodium I.P

397 D27068 Tab. Donepezil I.P

398 D27037 Tab. Escitalopram

399 D27017 Tab. Fluoxetine

400 D27012 Inj. Haloperidol I.P

401 D27006 Tab. Haloperidol I.P

402 D27020 Inj. Haloperidol Decanoate

403 D27043 Tab. Lithium Carbonate I.P

404 D27013 Tab. Lorazepam I.P

405 D27025 Inj. Olanzapine

406 D27046 Tab. Olanzapine I.P

407 D27052 Tab. Procyclidine I.P

408 D27015 Tab. Resperidone

409 D27056 Tab. Sertraline I.P

[97]

410 D27058 Tab. Sodi-Valporate CR

411 D27094 Tab. Thrihexyphenidyl

412 D27010 Tab. Thioridazine

413 D28014 Beclomethasone Inhaler I.P

414 D28019 Budesonide Inhaler

415 D28017 Tab. Doxofylline I.P

416 D28020 Respules Salbutamol B.P

417 D28022 Respules Salbutamol + Ipratropium

418 D28013 Salbutamol Inhaler I.P

419 D28018 Soln. Salbutamol Sulphate

420 D28004 Tab. Salbutamol Sulphate I.P

421 D28011 Syp. Salbutamol Sulphate I.P

422 D28001 Inj. Theophylline & Etophylline

423 D28003 Tab. Theophylline & Etophylline

424 D29003 I.V Compound Sodium Lactate Inj. I.P (Ringer's Lactate)

425 D29005 I.V Dextrose 10% I.P (10D)

426 D29004 I.V Dextrose 5% I.P(5D)

427 D29014 I.V Dextrose 25% I.P (D25)

428 D29002 I.V Dextrose and Sodium

Chloride Inj. I.P (DNS)

429 D29013 Inj. Calcium Gluconate I.P

430 D29016 Multi Electrolyte Infusion

[98]

431 D29006 Oral Soln. of Potassium Chloride

432 D29011 Inj. Pottasium Chloride I.P

433 D29009 Paediatric Maintenance Fluid

434 D29017 Hydroxy Ethyl Starch 6%

435 D29008 Inj. Sodium Bi-Carbonate I.P

436 D29012 Inj. Sodium Chloride I.P (NormalSaline) 0.9% W/V

437 D29018 Inj. Sodium Chloride I.P(NormalSaline) 3% W/V

438 D30001 Tab. Calcium & Vit. D3 (Film coated)

439 D30022 Calcium & Vit. D3 Suspension

440 D30025 Inj. Methylcobalamine

441 D30026 Tab. Pyridoxine I.P

442 D30010 Tab. Riboflavin I.P (coated)

443 D30002 Cap. Vit A I.P

444 D30009 Inj. Vit. A I.P

445 D30012 Vitamin A Solution (Concentrated) I.P

446 D30017 Vitamin A Solution (Concentrated)

447 D30007 Cap. Vit A.D (Therapeutic)

448 D30028 Inj. Vitamin B Complex

449 D30003 Cap. Vitamin B Complex

450 D30020 Syp. Vitamin B-Complex

451 D30006 Tab. Vitamin C I.P

452 D30016 Tab. Vitamin C (Chewable)

[99]

453 D30023 Vit. E Drop

454 D30029 Susp. Zinc Acetate

455 D30015 Tab. Zinc Acetate / Sulphate (Dispersible Tablets)

456 D34004 Absorbent Cotton I.P

457 D34002 Cotton Bandage IS 863

458 D34003 Cotton Cloth for Plaster of Paris Bandages, Variety - 1 IS : 4738

459 D34008 Roller Bandage IS 863

460 D34001 Handloom Cotton Gauze, Bleached IS 758 Absorbent,Non -Sterilised

461 D31018 Black Disinfectant Fluid (Phenyl) IS 1061

462 D31014 Bleaching Powder as per B.I.S.

463 D31040 Borax Glycerin

464 D31027 Gentian Violet

465 D31015 Tab. Halazone for Solution U.S.P

466 D31020 Tab. Sodium Dichloroisocyanurate

467 D31041 Soda Lime

468 D31001 Sterile Water For Injection I.P

469 D38001

RTI / STI Kit 1 Each Kit contains: Tab. Azithromycin (1 gm) IP – 1Tab. Tab. Cefixime 400mg) IP - Tab.

470 D38002

RTI / STI Kit 2 Each Kit contains : Tab.Secnidazole (1 gm) IP – 2Tab. Tab. Fluconazole 150mg) IP - Tab.

[100]

471 D38003

RTI / STI Kit 3 Each Kit contains: Inj. Benzathine Penicillin 2.4 MU IP-1 Vial and Tab. Azithromycin 1gm IP -1 Tab. And Sterilised Disposable syringe with 21G needle ( IS No. 12655) ( 1.5 inches) 10ml. – 1 No. and Sterile water for injection 10ml-1 No.

472 D38004

RTI / STI Kit 4 Each Kit contains : Cap / Tab. Doxycycline (100 mg.) IP-30 Tab./Cap. Tab. Azithromycin (1 gm.) IP – 1Tab.

473 D38005 RTI / STI Kit 5 Each Kit contains: tab. Cefixime 400mg – 21 Tab.

474 D38006

RTI / STI Kit 6 Each Kit contains: Tab. Cefixime (400 mg.) IP -1 Tab. And Tab. Metronidazole (400 mg.) IP -28 Tab. And Tab./cap. Doxycycline (100 mg.) IP -28 Cap./Tab.

475 D37007

RTI / STI Kit 7 Each Kit contains: Cap/ Tab. Doxycycline (100 mg.) IP-42 Tab./Cap. Tab. Azithromycin (1 gm) IP – 1Tab.

476 D32024

ART Regimen (Dual Drug) Dispersible Each Disp. Tab. Contain Lamivudine 30 mg. + Nevirapine 50 mg. + Stavudine 6 mg.

477 D32025

ART Regimen (Dual Drug) Each Tab. Contains Lamivudine 40 mg. + Nevirapine 70 mg. + Stavudine 10 mg.

478 D32026 ART Regimen (Triple Drug) Each Disp. Tab. Contain Lamivudine 430

[101]

mg. + Stavudine 10 mg.

489 D32027

ART Regimen (Dual Drug) Each Tab. Contains Lamivudine 40 mg. + Stavudine 10 mg.

490 D38010

Anti-TB Kit 2 Each kit contains : INH, IP – 50. : 1 Tab. RMP, IP – 100 mg. : Tab. PZN, IP – 250 mg. : Tab.

491 D38010 Anti-TB Kit 2

492 D11016

Blister Combipack (Tab. Rifampicin 100mg + INH (Isonicotinylhydrazine) 50mg + Pyrazinamide 300 mg.) Dispersible Kid Tab.

493 D11017

Blister Combipack (Tab. Rifampicin 100 mg. + INH (Isonicotinylhydrazine) 50 mg.) Dispersible Kid Tab.

494 D11018

Anti-TB Schedule – 5 Rifampicin 750 mg. – 1 Tab. Isoniazid IP 75 mg. – 1 Tab. Ehambutol IP 200 mg. – 1 Tab. Pyrazinamide IP 250 mg. – 1 Tab.

495 D11019

Anti-TB Schedule – 6 Rifampicin 75 mg. – 3 Tab. Isoniazid IP 75 mg. – 3 Tab. Pyridoxine HCL IP 5 mg. – 4 Tab.

496 D11020

Anti-TB Schedule – 7 Rifampicin 150 mg. – 1 Tab. Isoniazid IP 150 mg. – 1 Tab. Ethambutol IP 400 mg. – 1 Tab. Pyrazinamide IP 500 mg. – 1 Tab.

[102]

497 D11021

Anti-TB Schedule – 8 Rifampicin 150 mg. – 3 Tab. Isoniazid IP 150 mg. – 3 Tab. Pyridoxine HCL IP 5 mg. – 4 Tab.

498 D11030

Anti-TB - Cat-I - Intensive Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 1 Tab. Ethambutol IP 800 mg. – 1 Tab. Pyrazinamide IP 750 mg. – 1 Tab. Ehambutol IP 400 mg. – 1 Tab.

499 D11031

Anti-TB - Cat-I - Continuous Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab.

500 D11032

Anti-TB - Cat-II - Intensive Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab. Ethambutol IP 800 mg. – 2 Tab. Ethambutol IP 400 mg. – 2 Tab. Pyrazinamide IP 750 mg. – 2 Tab. Inj. Streptomycin Sulphate I.P – 0.75 mg. / Vial

501 D11033

Anti-TB - Cat-II - Continuous Phase Rifampicin 450 mg. – 1 Tab. Isoniazid IP 300 mg. – 2 Tab. Ethambutol IP 800 mg. – 2 Tab. Ethambutol IP 400 mg. – 2 Tab.

[103]

502 D14027 Tab. Artemether 60 mg. + Lumefantrine 360 mg. (Dispersible Tablet)

503 D38011 Tab. Artemether40mg + Lumefantrine240mg

504 D38014 Tab. Artemether 60 mg. + Lumefantrine 360mg.

505 D38012 Tab. Artemether 80 mg. + Lumefantrine 480 mg.

506 D38015 Susp. Artemether + Lumefantrine

507 D38016 Syp. Artemether + Lumefantrine

508 D38013

Tab. Anti-Malarial Combipack Containing Artesunate Tablet, Sulphadoxine and Pyrimethamine Tab.

509 D02011 Lignocaine Spray (Topical)

510 D02012 Lignocaine Topical Solution (4%)

511 D02013 Lignocaine Viscous Topical Solution

512 D02014 Inj. Lignocaine + Adrenaline IP

513 D02015 Inj. Levobupivacaine

514 D02016 Inj. Levobupivacaine

515 D02017 Inj. Ropivacaine Hydrochloride

516 D04039 Inj. Butorphanol Tartrate

517 D04050 Inj. Diclofenac Sodium Aquous Preparation IP

518 D04051 Diclofenac Suppository

519 D04023 Tab. Etoricoxib (Coated) IP

520 D04053 Cap. Indomethacin

521 D04035 Inj. Ketorolac Ketoralac Tromethamine inj. IP

[104]

522 D04054 Tab. Lornoxicam

523 D04041 Inj. Nalbuphine Hydrochloride

524 D04055 Tab. Naproxen IP

525 D04056 Inj. Paracetamol I.V IP

526 D04057 Paracetamol Rectal Suppository

527 D04058 Tab. Paracetamol

528 D04059 Tab. Serratiopeptidatase

529 D04060 Inj. Buprenorphine

530 D04061 Inj. Fentanyl Citrate

531 D39001 Tab. Leflunomide

532 D39002 Tab. Leflunomide

533 D08009 Tab. Ivermectin

534 D08010 Tab. Praziquintal

535 D08011 Inj. Sodium Stibo Gluconate

536 D05026 Inj. Hydrocortisone Sodium Succinate (with diluents in plastic container)

537 D05027 Tab. Hydrocortisone

538 D05028 Tab. Levocetirizine DiHCl + Monteleukast

539 D05016

Syp. Levocetirizine (Palatable, with measuring cap and plastic container as per I.P)

540 D05029 Inj. Methylprednisolone

541 D05030 Inj. Methylprednisolone

542 D05031 Tab. Methylprednisolone

[105]

543 D05032 Inj. Triamcinolone Acetonide

544 D23016 Tab. Carbimazole

545 D23017 Tab. Gliclazide

546 D23018 Tab. Glimepride

547 D23019 Pen Insulin

548 D23020 Pen Insulin (25% / 75%)

549 D23021 Pen Insulin (50% / 50%)

550 D23022 Inj. Insulin Glargine

551 D23023 Tab. Levo Thyroxine Sodium I.P

552 D23003 Inj. Mixed Gas Gangrene Antitoxin I.P

553 D23024 Tab. Propylthiouracil I.P

554 D23025 Tab. Vildagliptin

555 D07023 Inj. Citicolin

556 D07024 Tab. Citicolin

557 D07025 Syp. Levetiracetam

558 D07026 Tab. Levetiracetam

559 D09113 Tab./Cap. Amoxycillin & Clavulanic Acid

560 D09112 Inj. Amoxycillin + Clavunic Acid (with diluents in plastic container)

561 D09109

Amoxycillin Dry Syrup (Palatable, plastic container as per I.P with Dropper)

562 D09056 Inj. Ampicillin Sodium I.P

563 D09143 Inj. Azithromycin (with diluents in plastic

[106]

container)

564 D09144 Inj. Aztreonam (with diluents in plastic container)

565 D09145 Inj. Aztreonam (with diluents in plastic container)

566 D09146 Inj. Cefipime + Tazobactam (with diluents in plastic container)

567 D09147 Tab. Cefixime & Clavulanic Acid

568 D09148 Inj. Cefoperazone + Sulbactam (with diluents in plastic container)

569 D09149 Tab. Cefuroxime Axetil I.P

570 D09154 Inj. Clarithromycin (with diluents in plastic container)

571 D09155 Inj. Doripenem Monohydrate (with diluents in plastic container)

572 D09156 Tab. Gemifloxacin I.P

573 D09157 Inj. Imipenem + Cilastatin Sodium I.P

574 D09158 Inj. Imipenem + Cilastatin Sodium (with diluents in plastic container)

575 D09159 Levofloxacin Infusion

576 D09161 Inj. Netlilmicin

577 D09162 Inj. Polymixin B Sulphate (with diluents in plastic container)

578 D09163 Roxythromycin Drop

579 D09164 Inj. Tigecycline

580 D13010 Inj. Ofloxacin + Ornidazole

[107]

581 D13011 Inj. Tinidazole IV

582 D40001 Inj. Gancyclovir

583 D40002 Cap. Oseltamivir I.P

584 D40003 Tab. Telbivudine

585 D40004 Tab. Tenofovir Disoproxil Fumarate I.P

586 D12021 Inj. Amphotericine B Liposomal I.P

587 D12022 Inj. Caspofungin

588 D12023 Tab. Voriconazole

589 D12024 Inj. Voriconazole

590 D20006 Tab. Acetazolamide I.P

591 D20007 Tab. Hydrochlorothiazide I.P

592 D20011 Tab. Metolazone

593 D20013 Inj. Torsemide

594 D20015 Tab. Torsemide

595 D17079 Inj. Papaverine HCl

596 D25030 Atropin Eye Drop

597 D25032 Chlorhexidine Oral Gel

598 D25033 Cyclopantolate Eye Drop I.P

599 D25034 Difluprednate + Moxifloxacin Eye Drop

600 D25035 Moxifloxacin Eye Drop I.P

601 D25036 Dorzolamide Eye Drops

602 D25037 Fluorescein-Stain Strip

[108]

603 D25039 Hypromellose Eye Drop

604 D25040 Inj. Hydroxypropyl Methylcellulose

605 D25041 Natamycin Eye Drop

606 D25042 Ofloxacin + Clotrimazole + Demamethasone Ear Drop

607 D25043 Ofloxacin + Demamethasone Eye / Ear Drop

608 D25008 Pilocarpine Eye Drops I.P

609 D25044 Proparacaine Eye Drop

610 D25045 Salmeterol Xlnafoate + Fluticasone Proprionate Inhaler I.P

611 D25046 Terpentine Oil + Chlorbutor + Paradichloro Benzene Ear Drop

612 D25047 Xylometazoline Hydrochloride Nasal Drop

613 D25048 Xylometazoline Hydrochloride Nasal Drop

614 D29019 Inj. Glycine

615 D29020 Inj. Invert Sugar I.V

616 D29021 Plasmaexpander Infusion Pentastarch

617 D29022 I.V Sodium Chloride (Normal Saline)

618 D29023 I.V Sodium Chloride (Normal Saline)

619 D29024 Tab. Tolvaptan

620 D05033 Tab. Mycophenolate Mofetil

621 D05034 Tab. Mycophenolate Mofetil

622 D05035 Tab. Mycophenolate Sod.

623 D05036 Tab. Mycophenolate Sod.

[109]

624 D05037 Tab. Tacrolimus

625 D05038 Tab. Tacrolimus

626 D05020 Cap. Thaliodamide

627 D33080 Inj. Bortezomib

628 D33049 Tab. Cyclophosphamide (coated)

629 D33081 Tab. Cyclophosphamide (coated)

630 D33082 Syp. Cyclosporine

631 D33067 Cap. Cyclosporine

632 D33083 Cap. Cyclosporine

633 D33084 Inj. Dacarbazine

634 D33085 Inj. Dacarbazine

635 D33086 Tab. Nilotinib

636 D33087 Tab. Nilotinib

637 D33088 Inj. Paclitaxel

638 D33089 Inj. Paclitaxel

639 D33090 Inj. Rituximab

640 D33091 Inj. Rituximab

641 D33092 Tab. Tamoxifen

642 D33093 Tab. Tamoxifen

643 D33094 Tab. Tamoxifen

644 D21033 Tab. Drotaverine HCl

645 D21039 Inj. Hyoscine Butylbromide

[110]

646 D21040 Inj. Levosulpiride

647 D21041 Inj. L-ornithine-L-aspartate

648 D21042 Inj. Octreotide

649 D21034 Inj. Palonosetron

650 D21043 Inj. Peginterferon Alfa-2a

651 D21044 Inj. Peginterferon Alfa-2a

652 D21045 Inj. Peginterferon Alfa-2b

653 D21046 Inj. Peginterferon Alfa-2b

654 D21047 Tab. Sulphasalazine

655 D41001 Tab. Alfuzosin

656 D41002 Tab. Derifenacin

657 D41003 Tab. Derifenacin

658 D41004 Cap. Dutasteride

659 D41005 Tab. Flavoxate

660 D41006 Cap./Tab. Tamsulosin

661 D26019 Inj. 17 Hydroxy Progesterone Capreote

662 D26020 Inj. 17 Hydroxy Progesterone Capreote

663 D26021 Tab. Estradiol

664 D26022 Tab. Estradiol

665 D26023 Inj. Human Chorionic Gonadotrophin

666 D26024 Inj. Human Menopausal Gonadotrophin

667 D26025 Inj. Human Menopausal Gonadotrophin

[111]

668 D26026 Tab. Medroxy Progesterone

669 D26027 Cap. Micronised Progesteron

670 D26018 Tab. Magnesium Sulphate

671 D18034 Framycetin Cream

672 D18035 Tab. Isotretinoin

673 D18036 Cap. Itraconazole

674 D18037 Ointment Neomycin

675 D18038 Povidone Iodine Mouth Wash

676 D18039 Povidone Iodine Solution

678 D18040 Cream Sertaconazole Nitrate

679 D18041 Sertaconazole Nitrate Vaginal Pessary

680 D18042 Tab. Finasteride

681 D18043 Tacrolimus Ointment

682 D18044 Tacrolimus Ointment

683 D42001 Tab. Baclofen

684 D42002 Tab. Clopidogrel + Aspirin

685 D42003 Inj. Interferon Beta 1a

686 D42004 Tab. Tetrabenazine

687 D17060 Tab. Carvidolol

689 D17061 Tab. Clonidine HCl

690 D17062 Inj. Enalapril

691 D17063 Tab. Enalapril Maleate

[112]

692 D17064 Tab. Ivabradine

693 D17065 Inj. Levosimendan

694 D17014 Tab. Lisinopril

695 D17066 Tab. Losartan Potassium

696 D17067 Tab. Olmesartan

697 D17068 Tab. Ranolazine

698 D17069 Inj. Reteplase

699 D17070 Tab. Rosuvastatin

700 D17071 Inj. Tenecteplase

701 D17072 Tab. Verapamil

702 D17073 Tab. Verapamil

703 D17074 Tab. Verapamil

704 D17075 Tab. Glyceriletrinitrate

705 D17076 Tab. Propranolol

706 D17077 Tab. Ranolazine

707 D17078 Tab. Trimetazidine

708 D16024 Tab. Deferasirox

709 D16025 Inj. Desferrioxamin

710 D16040 Tab. Eltrombopag

711 D16041 Inj. Erythropoitin

712 D16042 Inj. Erythropoitin

713 D16043 Inj. Erythropoitin

[113]

714 D16044 Inj. Ferric Carboxy Maltose

715 D16045 Inj. Methoxy Polythene Glycon Epoetinbta

716 D43001 7% Amino Acid for kidney

717 D43002 8% Amino Acid for liver

718 D43003 Inj. Amino Acid I.V

719 D43004 Inj. Amino Acid I.V

720 D43005 Inj. Dobutamine HCl

721 D43006 Inj. Dobutamine HCl

722 D43007 Inj. Fat Emulsion I.G

723 D43008 Inj. Fat Emulsion I.G

724 D43009 Inj. Fat Emulsion 10%

725 D43010 Inj. Fat Emulsion 20%

726 D43011 Inj. Isoprenalin HCl

727 D43012 Multivitamin Injection

728 D43013 Inj. Sodium Nitroprusside

729 D43014 Inj. Sodium Tetradecyl Sulfate

730 D44001 Inj. Human Albumin

731 D44003 Inj. Human Albumin IV

732 D44004 Syp. Lactulose

733 D44005 Inj. Octreotide

734 D44006 Tab. Rifaximin

735 D44009 Inj. Terlipressin Acetate

[114]

736 D44010 Tab. Ursodeoxycholic Acid

737 D44011 Tab. Ursodeoxycholic Acid

738 D45001 Barium Sulphate HD contrast

739 D45002 Barium Sulphate single contrast

740 D45009 Inj. Iopamidol

741 D45010 Inj. Iopamidol

742 D45011 Inj. Meglumine Diatrizoate

743 D45012 Inj. Meglumine Diatrizoate

744 D45013 Inj. Meglumine diatrizoate + Sodium Diatrizoate

745 D45014 Inj. Meglumine diatrizoate + Sodium Diatrizoate

746 D45016 Pedicloryl Oral Solution

747 D46001 Idoform

748 D46002 Benzoin

749 D46003 Storax

750 D46004 Sodium Hypochlorite Solution

751 D46005 Zinc Oxide

752 D46006 Eugenol

753 D46007 Solvent Ether

754 D30031 Tab. Vit. D3

755 D30032 Inj. Vit. D3

756 D30033 Vit. D3

[115]

757 D30034 Tab. Vit. D3

758 D30035 Tab. Calcium Citrate Maleate + Calcitrol + Vit. K27

759 D30036 Tab. Ferrous Sulphate + Folic Acid + Methylcobalamine

760 D30037 Tab. Folic Acid + Pyridoxine + Methylcobalamine

761 D31042 Budesonide Repsules

762 D31043 Inj. Calcium Chloride

763 D31044 Tab. Formaldehyde (Formalin)

764 D31045 Tab. Isoprenaline Sulfate

765 D31046 Tab. Nikorandril

766 S02113 Whole Blood Finger Prick Test Kit for HIV

767 S02130 Hydrogen Sulphide (H2S) strip test kit

768 S02109 Monovalent Rapid Diagnostic Test Kits

769 S02110 Bivalent Rapid Diagnostic Test Kit

770 S02131 Ortho-toluidine Kit (OT Kit)

771 S02053 RPR Test Kit for Syphilis

772 S01001

Black Braided SilkSize:- 1, ( Non Sterile) 25mt. / Reel (without needle) U.S.P, with CE certification

773 S01002

Black Braided SilkSize:- 1-0, ( Non Sterile) 25mt. / Reel (without needle) U.S.P, with CE certification

774 S01003 Black Braided SilkSize:- 1-0, length: 76cm, 1 / 2 Circle Round Bodied 30

[116]

mm needle (Sterilized) U.S.P, with CE certify

775 S01004

Sterilised Surgical Suture Black Braided SilkSize:-1, length: 2 x 75cm, ( Precut and Pre Sterilized) U.S.P, with CE certification

776 S01005

Sterilised Surgical Suture Black Braided SilkSize:- 1-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

777 S01006

Sterilised Surgical Suture Monofilament Polyamide BlackSize:-1, length: 2 x 76cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

778 S01007

Sterilised Surgical Suture Monofilament Polyamide BlackSize:-1-0, length: 2 x 76cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

779 S01008

Catgut PlainSize:- 1-0, length: 1 x 152cm,U.S.P,with CE certification

780 S01009 Catgut PlainSize:-2-0, length: 1 x 152cm, U.S.P,with CE certification

781 S01010

Catgut ChromicSize:- 1, length: 1 x 152cm, (without needle) U.S.P, with CE certification

782 S01011

Catgut ChromicSize:-1-0, length: 1 x 152cm, (without needle) U.S.P, with CE certification

783 S01012

Catgut Chromic AtraumaticSize:- 1-0, length: 76cm, 1/ 2 Circle Round Bodied (45mm

[117]

needle) U.S.P,with CE certification

784 S01013

Catgut Chromic AtraumaticSize:-1, length: 76cm, 1/ 2 Circle Round Bodied (40mm needle) (Heavy) U.S.P,with CE certification

785 S01014

Catgut Chromic AtraumaticSize:- 1-0, length: 76cm, 1/ 2 Circle Round Bodied (40mm needle) U.S.P,with CE certification

786 S01015

Catgut Chromic AtraumaticSize:-1-0, length: 76cm, 1/ 2 Circle Round Bodied (30mm needle) U.S.P,with CE certification

787 S01016

PolypropyleneSize:- 1, length: 70cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

788 S01017

PolypropyleneSize:- 1-0, length: 70/90cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

789 S01018

PolyglactinSize:-1, length: 90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

790 S01019

PolyglactinSize:- 1-0, length: 90cm, 1/2 Circle Round Bodied 40mm (needle) U.S.P,with CE certification

791 S01042 Poly Propylene MeshSize:- 15xSize:- 15cm, with CE certification

792 S01043 Absorbable Polyglactin Mesh + Poly PropyleneSize:- 15xSize:-

[118]

15cm, with CE certification

793 S01044

Absorbable Polyglactin Mesh + Poly PropyleneSize: 6 x 11cm, with CE certification

794 S01045

Sterilised Surgical Suture Black Braided SilkSize:-2, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

795 S01046

Sterilised Surgical Suture Black Braided SilkSize:- 3-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

796 S01047

Sterilised Surgical Suture Black Braided SilkSize:- 4-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

797 S01048

Sterilised Surgical Suture Monofilament Polyamide BlackSize:- 3-0, ( Precut & Pre Sterilized) U.S.P, with CE certification

798 S01049

Sterilised Surgical Suture Monofilament Polyamide BlackSize:- 4-0, ( Precut & Pre Sterilized) U.S.P, with CE certification

799 S01050

PolypropyleneSize:- 2, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P, with CE certification

800 S01051

S01051 - PolypropyleneSize:- 3-0, length: 70/90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P, with CE certificatio

801 S01052

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 16mm (with needle) U.S.P, with CE certification

[119]

802 S01053

PolypropyleneSize:- 2-0, length: 70/90cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

803 S01056

PolypropyleneSize:-3-0, length: 70cm, 1/2 Circle Round Bodied 25-30mm (needle) U.S.P,with CE certification

804 S01057

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 30mm (needle) U.S.P,with CE certification

805 S01058

PolyglactinSize:- 3-0, length: 90cm, 1/2 Circle Round Bodied 26-30mm (Needle) U.S.P,with CE certification

806 S01059

PolyglactinSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 16mm (Needle) U.S.P,with CE certification

807 S01062

PolyglactinSize:- 5-0, length: 45cm, 1/2 Circle Round Bodied 12mm (needle) U.S.P,with CE certification

808 S01068

Black Braided SilkSize:- 2-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certifi

809 S01069

Black Braided SilkSize:-3-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certific

810 S01070

Black Braided SilkSize:- 4-0, length: 76cm, 1 / 2 Circle Round Bodied 20 mm needle (Sterilized) U.S.P, with CE certifi

[120]

811 S01071

Sterilised Surgical Suture Black Braided SilkSize:-2-0, length: 2 x 75cm, ( Precut AND Pre Sterilized) U.S.P, with CE certification

812 S01072

Catgut Chromic AtraumaticSize:-2-0, length: 76cm, 1/ 2 Circle Round Bodied (45mm needle) U.S.P,with CE certification

813 S01073

Catgut Chromic AtraumaticSize:- 3-0, length: 76cm, 1/ 2 Circle Round Bodied (20mm needle) U.S.P,with CE certification

814 S01074

Catgut Chromic AtraumaticSize:- 4-0, 1/ 2 Circle Round Bodied (45mm needle) U.S.P, with CE certification

815 S01075

PolypropyleneSize:- 2-0, length: 70cm, 1/2 Circle Round Bodied 20-30mm, with needle U.S.P, with CE certification

816 S01076

PolypropyleneSize:- 3-0, length: 70cm, 1/2 Circle Round Bodied 20mm, with needle U.S.P,with CE certification

817 S01077

PolypropyleneSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 20mm (with needle) U.S.P, with CE certification

818 S01078

PolyglactinSize:- 2, length: 90cm, 1/2 Circle Round Bodied 40mm (Heavy needle) U.S.P,with CE certification

819 S01079 PolyglactinSize:- 2-0, length: 90cm, 1/2 Circle Round Bodied 26-30mm

[121]

(needle) U.S.P,with CE certification

820 S01080

PolyglactinSize:- 3-0, length: 70cm, 1/2 Circle Round Bodied 20mm (Needle) U.S.P,with CE certification

821 S01081

PolyglactinSize:- 4-0, length: 70cm, 1/2 Circle Round Bodied 20mm (Needle) U.S.P,with CE certification

822 S01082

PolyglactinSize:- 5-0, length: 45cm, 1/2 Circle Round Bodied 16-20mm (needle) U.S.P,with CE certification

823 S01083

Monofilament Polyamide Black Breaded SilkSize:- 2-0, 3/8 Circle Bodied 45mm needle, reverse cutting

824 S02001

Disposable Syringes With colour coded (as per BIS) needle Sterilised, Luer Mount, Non - toxic 2 CC, 5 CC, 10 CC, 20 CC, 50 CC as per IS :10258

825 S02003

Disposable sterilised Needles in blister pack20 G - 24 G, IS No: 10654: 2002, ISO: 7864.1993 with CE certificate

826 S02004

Disposable Tuberculin / B.C.G Syringes1CC / ml, With Needle Sterilised Non-Sterilised Toxic 1CC / ml. As per Drugs & Cosmetic Act 1940, w

827 S02005

Disposable Insulin Syringes40 Unit, With Needle, Sterilised Non -Toxic, Unit 40 with CE certification

828 S02006 Disposable Insulin Syringes100 Unit, With

[122]

Needle, Sterilised Non-Toxic, Unit 100 with CE certification

829 S02007

Disposable Sterilised Tuberculin / Insulin NeedleIn Blister Pack with CE certification

830 S02008

Intra CathAdult, (two way) with closing Cover Type II Sterilised Size 18, 20,22 (Adult) with CE certification

831 S02009

Intra CathChild, (two way) with closing Cover Type II Sterilised Size 24 (Child) with CE certification

832 S02011

Intravenous SetAdult, With built in Airway moulded chamber and Needle, Sterile, Disposable, Non - Toxic, Non Pyroge

833 S02012

Intravenous SetChild, With built in Airway moulded chamber and Needle, Sterile, Disposable, Non - Toxic, Non Pyroge

834 S02013

Blood Administration SetDisposable Sterilised by ETO as per Drugs and Cosmetics Act-1940, I.S. No. 9824 (part 3 of 1996) wit

835 S02014

Surgical NeedlesSuture Needles, Straight Cutting Needle different sizes 6 to 10

836 S02015

Surgical NeedlesSuture Needles, Curved Cutting Needle different sizes 6 to 10

837 S02016

Surgical NeedlesSuture Needles, Curved Round Bodied different sizes 6 to 10

838 S02018 Surgicals BladesPre - sterile with Gamma radiation for handle no. 4

[123]

sizes 10 , 12 ,15,20,22, 24, ISI : 3319:1995 wit

839 S02024

Foleys Urinary CatheterSize: 16 & 18, Silkolatex (Pre - sterile) 2 way sterile, Non - toxic with CE certification

840 S02025

Foleys Urinary CatheterSize: 16, 18 AND 20, Silkolatex (Pre - sterile) 3 way sterile, Non - toxic with CE certification

841 S02026

Urinary Drainage BagSterilised with non return valve and Drainage outlet with a capacity of 2000ml , with marking non to

842 S02031

Ryle’s TubePolythene ( P.V.C) Pre -sterile (Length 105ms) Sterile Non toxic , Pyrogen free , with Radio Opaque

843 S02034

Operation Gloves (Sterilised)BIS specifications gloves, surgical rubber made ofHypoallergic latex.-100% electronically tested, ste

844 S02037 Sterile Disposable Blood Lancet (Pricking Needle).

845 S02045

Auto disable syringes sterilised2 CC, (as per WHO, UNICEF specification), 2CC, 21G-25G needle with CE certification IS : 10258 (Part – 3)

846 S02046

Auto disable syringes sterilised5 CC, (as per WHO, UNICEF specification), 5CC, 21G-25G needle with CE certification IS : 10258 (Part – 3)

[124]

847 S02049

Disposable Examination Gloves6", 61/2", 7", 71/2",Sterilised, small, medium and large,pre-powdered, with CE certified,surgical rubb

848 S02051 Umbilical cord clamp / Vascular clamp (sterilised).

849 S02053

VDRL Rapid Test Kit, (RPR) Rapid Plasma Regime.AS PER TENDER SPECIFICATION

850 S02078 N 95 facemasks As per Tender Specification

851 S02092

Spinal Needle Disposable Adult as per BIS23 / 25G (70 - 90mm) with hub (Colour coaded as per ISO Standard

852 S02094

Disposable Syringes 20 CC, with colour coded (as per BIS) needle Sterilised, Luer Mount, Non - toxic CGS 10CC as per Dr

853 S02095 Naso-Gastric Tube (Infant feeding tube)Size 5, 6

854 S02096

Suction catheter (Plain)Size 6 Fr and 8 Fr with colour code Length: Neonatal - 30cm, Paediatric - 40cm and Adult - 50cm. IS

855 S02097 Endotracheal TubeSize 2.5, 3, 3.5, 4 ISO Certified Product

856 S02101

Three Way StopcockThree Caps. (Blue, Green and Red Colour), Sterile, non-pyrogenic. ISO Certified Product. S02107 - Epidural SetEpidurarl Syringe - 1,Epidural Needle - 18G - 1,Epidural Catheter

857 S02109 Monovalent Rapid Diagnostic Test KitsAs per

[125]

tender specification

858 S02110 Bivalent Rapid Diagnostic Test KitAs per tender specification

859 S02111 NS1 Elisa Kit For Dengue TestAs per tender specification

860 S02118 Disposable Delivery Kit (ETO Sterilised)AS PER TENDER SPECIFICATION

861 S02119

PAP Smear KitCusco Vaginal Speculum - 1 piece, Endocervical Brush - 1 piece, Wooden Ayers Spatula - 1 piece, Glas

862 Mosquito Larvicide Oil (MLO)

863 Temephos (50%) EC

864 Deltamethrin Flow 2.5 %

865 Pyrethrum Extract (2%)

866 Diflubenzuron 25% WP

867 Bivalent Rapid Diagnostic Test Kit for Maleria

868 NS1 Elisa Kit for Dengue Test

869 Anastrazole tab I.P.

870 Aprepetant Tab.

871 Arsenic trioxide I.P

872 Bendamustine Inj.

873 Bevacizumab Inj.

874 Bicalutamide Tab. I.P

875 Bortezomib Inj.

[126]

876 Cabazitaxel Inj.

878 Capecitabine Tab. I.P

879 Carboplatin Inj. I.P

880 Cetuximab Inj.

881 Chlorambucil Tab. I.P

882 Cladribine Inj.

883 Cytarabine Inj.

884 Dacarbazine Inj.

885 Dactinomycin Inj.

886 Daunorubicin Inj. I.P

887 Decitabine Inj.

888 Desfeprioxamine Inj. I.P

889 Docetaxel Inj. I.P

890 Docetaxel lyophilized Inj.

891 Doxorubicin rtu inj

892 Doxorubicin liposomal Inj.

893 Epirubicin Inj

894 Erlotinib Tab. I.P

895 Estramustine Tab.

896 Everolimus Cap.

897 Exemestane TaB.

898 Filgrastim pfs Inj.

[127]

899 Figrastim Inj. I.P

900 Filgrastim peg Inj.

901 Fludarabine Tab.

902 Fludarabine Inj. I.P

903 Fulvestrant Inj.

904 Gefitinib Tab.

905 Ibandronic acid Inj.

906 Idarubicin Inj.

907 Ifosfamde with mesna Inj.

908 Lenalidomide Cap.

909 Letrozole Tab.

910 Leucovorin calcium Inj. I.P

911 Leuprolide acetate Inj.

912 Lomustine Cap.

913 Megestrol Tab. I.P

914 Melphalan Tab. I.P

915 Mercaptopurine (6-mp) Tab. I.P

916 Mesna inj.

917 Mitomycin-c inj.

918 Mitoxantrone Inj.

919 Nilotinib Cap.

920 Mimotuzumab Inj.

[128]

921 OxaliplatinInj.

922 Oxaliplatin rtu Inj.

923 Paclitaxel nanoparticle Inj.

924 Pazopanib Tab.

925 Pemetrexed inj.

926 Procarbazine Cap.

927 Rasburicase Inj.

928 Rituximab Inj.

929 Sargramostim Inj.

930 Sorafenib Tab.

931 Sunitinib Cap.

932 Tamoxifen Tab.

933 Temozolamide Cap.

934 Temsirolimus Inj.

935 Thalidomide Cap.

936 Zoledronic acid Inj.

937 Trabectedin Inj.

938 Trastuzumab Inj.

939 Tretinoin Cap.

940 Vinorelbine Inj.

941 D27027 Amisulpride

942 D27028 Amitriptyline + Chloridezepoxide

[129]

943 Carbamazepine CR

945 D27071 Chlorodiazepoxide Tab.

946 D27032 Dothiepin Tab.

947 D27043 Lithiumcarbonate Tab. I.P

948 D05021 Tab. levocetrizine

949 D27043 Nitrazepam Tab.

950 D27046 Olanzapine

951 D27048 Olanzapine

952 D27052 Procyclidine Tab. I.P

953 D07004 Tab Phenytoin Sodium

954 D27054 Quetiapine Fumarate Tab. I.P

956 D27061 Trifluperazine + Trihexyphenidyl Tab.

957 D27010 Thioridazine

958 D27020 Inj Haloperidol-LA

959 Inj Phenytoin I.P

960 D07010 Inj Lorazepam

961 D21005 Inj Promethzine HCL

962 D14018 Inj Artasunate

963 D09078 Inj Cefoporazone + Salbactum

964 D17013 Inj Dopamine HCL

965 D09007 Inj.Ciprofloxacian iv

967 D05001 Inj.Dexamethasone Sodium phosphata

[130]

968 D30003 Cap Vitmin B. complex

969 Rectified Spirit I.P

970 ECG Jelly

971 Micropore

972 Inj Fluanxol Decanoate

973 Inj Zuclopenthixol Decanoate

974 Sodium Fluoride (18F) Inj. I.P

975 EDTA powder